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ABSTRACT
NATIONAL AND LOCAL ANTIBIOTIC PRESCRIBING TRENDS AND PRESCRIBING
APPROPRIATENESS IN OLDER ADULTS
By Fawaz Alotaibi, Ph.D. Candidate., MS., Pharm.D.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2019
Advisor: Patricia W. Slattum, Pharm.D., Ph.D., BCGP
Director, Geriatric Pharmacotherapy Program
Victor A. Yanchick Professor of Pharmacotherapy and Outcomes Science
Background: Antibiotic overuse/misuse has been documented in several reports to
increase the risk of Clostridioides difficile (C.diff) infection and antibiotic resistance. The
older adult population is more prone to use antibiotic medications than any other age
group due to decreased immune function, use of urinary catheters, ventilation during
hospitalization and other factors. Antibiotic resistance and C.diff are major public health
problems. However, studies examining the trends of antibiotic use and the association
between the antibiotic use and negative health outcomes among older adults in the
outpatient and emergency department settings are limited.
Objectives: The main objectives of this dissertation were to: 1) calculate the national
antibiotic trends among community-dwelling older adults in the United State; 2) evaluate
the antibiotic trends and antibiotic appropriateness among older adult patients visiting
the geriatrics clinic and adult internal ambulatory care clinic at VCU Health; and 3)

xi

examine the antibiotic trends and antibiotic appropriateness among older adult patients
and middle-aged patients visiting the emergency department at VCU Health.
Methods: For the first objective, data were obtained from Medical Expenditure Panel
survey (MEPS) a nationally representative dataset (2011-2015). Descriptive analyses
were conducted and multiple logistic regression was performed to assess the
association between the antibiotic use and demographic and sociodemographic
characteristics. In the second objective, data were obtained from VCU Health outpatient
clinics (geriatrics, and Internal medicine ambulatory care clinic only). Descriptive
statistics were calculated and multiple logistic regression was performed to assess the
association between antibiotic appropriateness and type of clinics and other
demographic characteristics. In the third objective, the emergency department
electronic medical records at VCU were used. Trend analysis was performed across the
dissertation studies using the Cochran–Armitage test. All variables were considered
statistically significant at an α level of 0.05. All the statistical analyses were conducted
using the Statistical Analysis Software Version 9.4 (SAS v.9.4), (SAS Institute Inc, Cary,
NC).
Results: There were 105,762,134 prescriptions dispensed to older adults in the
outpatient setting in the US from 2011 to 2015. Antibiotic prescriptions were more
common among women (18%) compared to men (12%). White participants received
more antibiotics (27%) than African Americans (1.77%) and others (1.4%).
Among the 3,515 patients who visited either Geriatrics or Internal Medicine ambulatory
clinic at VCU Health from 2012-2017, 1,534 antibiotics were prescribed. Potentially

xii

inappropriate antibiotic prescriptions were similar between the two clinics (30% in
Geriatrics clinic and 28% in Internal Medicine ambulatory clinic) with p-value of 0.08.
In addition, 6,343 middle-aged or older adult patients were dispensed and prescribed an
antibiotic in the ED at VCU Health from (2012 to 2017). Eighteen percent of the
antibiotic prescriptions received by middle age group were considered potentially
inappropriate, compared to 9% among the older adult patient (p < 0.0001).
Conclusions: The rate of antibiotic use overall remains unchanged despite the national
and international efforts to reduce antibiotic prescriptions and eventually to reduce
antibiotic resistance. The changes in the patterns of use in some of the antibiotic
categories appear to be driven more by the safety concerns rather than reducing overall
use. Future research is needed to strengthen antibiotic stewardship programs for older
adults in outpatient settings.
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CHAPTER ONE: INTRODUCTION
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Antibiotic Therapy:
Antibiotics are one of the most significant discoveries in human history. Antibiotics
are defined as a medication that inhibits the growth of or destroys microorganisms.
Through serendipity, a Scottish bacteriologist, Alexander Fleming, left a culture of
staphylococci uncovered in his lab and came back to discover that mold that grew there
was attacking the bacteria. That observation marked the beginning of the penicillin
revolution in 1925, the first antibiotic in history.1,2 Following the introduction of penicillin,
the leading causes of death shifted from communicable diseases to non-communicable
diseases such as heart diseases and cancer. In the United States, the average life
expectancy rose from 47 years to 78 years during the antibiotic era.3 The percentage of
older adults in the United States (U.S.) population increased from 4% to 13% as well. 4
Compared with other age groups, the older adult population has the highest antibiotic
consumption rate. The antibiotic prescription rate in the U.S. decreased among children
and adolescents from 2000 to 2010 and increased by 30% among the older adults over
the same time period.5
A recent study conducted by Olesen, et al. using Medicare Part D data reported that
19.5 million antibiotic prescriptions were claimed to Medicare beneficiaries from 2011 to
2015.6 The prescription rate was similar over the study period, with 1364.3 claims per
1000 beneficiaries. Of those claims, 552 per 1000 beneficiaries were considered
potentially inappropriate. Another nationally representative study that captured 86% of
all ambulatory outpatient prescriptions in the U.S. reported that 51.6 million antibiotic
prescriptions were prescribed to older adult patients in 2014.7 The rate of antibiotic
prescribing (1115 prescriptions per 1000 persons) was lower than reported by Olesen,
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et al.,6 but differences in the study population in terms of health insurance or patients’
characteristics and diseases severity might explain this discrepancy. Fleming-Dutra et
al.,8 reported that 30% of outpatient antibiotic prescriptions among all ages were
inappropriate in 2011. Older adults, in particular, received 617 prescriptions per 1000
persons and 18% of those prescriptions were deemed inappropriate. Table 1.1 presents
the recent literature that examined the antibiotic prevalence among US adults
population. There are still limited reports describing antibiotic use and antibiotic
appropriateness among the older adult population in the U.S., a knowledge gap that we
are hoping to address with this research.
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Table 1.1 A summary of the recent studies that examine the antibiotics rate among the US population.
Author

Study Settings

Study Population

Lee, Grace C., et al.

MEPS data from
2000-2010

US civilian, noninstitutionalized
population

Fleming-Dutra,
Katherine E., et al.

2010-2011 National
Ambulatory Care
Survey and National
Hospital Ambulatory
Medical Care Survey.

US population

184,032
sampled
ambulatory
care visits

Kabbani, Sarah, et al.

2011-2014 of IQVIA
Xponent database

US older adults
visiting the outpatient
settings

Sanchez, Guillermo
V., et al.

2008-2011 2010-2011
National Ambulatory
Care Survey
1995-2002 National
Ambulatory Care
Survey and National
Hospital Ambulatory
Medical Care Survey.
2011 IMS Health
Xponent database

US population
related Macrolide
visit
US adults 18 year or
older

51.6 million
prescriptions
were
dispensed in
2014
2399

Roumie, Christianne
L., et al.

Hicks, Lauri A., et al.

US population

Sample
Size
1.4 billion
outpatients
records

Unknown

Unknown

Conclusion
The antibiotic prescription rate in the
U.S. decreased among children and
adolescent from 2000 to 2010 and
increased by 30% among older adults.
12.6% of US Ambulatory care visits
were associated with antibiotic
prescriptions. 18% of the antibiotic
prescriptions were considered
inappropriate among the older adult
population.
The rate of antibiotic prescriptions
remains the same over the study period
(1,115 prescriptions/1,000 persons)

Only 5% of macrolide prescribing is
following the guidelines which
macrolides are a first line therapy.
Overall antibiotic rate remains the
same over the study period from 302.4
in 1996 to 304.1 in 2002.

In 2011, health care providers
prescribed over 260 million of
antibiotics in the outpatient setting. The
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Mundkur, Mallika L.,
et al.

2006-2015 Optum
Clinformatics
Datamart

US adult population

Olesen, Scott W., et
al.

2011-2015 Medicare
US national
healthcare program
database

US older adult
population

Suda, Katie J., et al.

2006-2010 IMS Health US adult population
Xponent

overall rate of antibiotic was 842
prescriptions per 1000 persons. Older
adults received 1048 prescriptions per
1000 persons, which is the highest rate
compared to other age groups.
Unknown
The rate of antibiotic prescription
decreased significantly (5%) among
older adults from 991 to 943
prescriptions/1000 persons over the
study period.
4.5 million
The antibiotic use remains the same
Medicare
over the time period with 1364
beneficiaries prescriptions per 1000 beneficiaries
during the study period. 40% of the US
Medicare beneficiaries have received
potentially inappropriate antibiotics.
Unknown
Overall, 1.34 billion antibiotic
prescriptions were dispensed from
2006-2010. The antibiotic rate declined
by 2.8% over the study period from
892.21 to 867.58/1000 population.
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Antibiotic Complications:
Evidence shows that allergic reactions, antibiotic resistance, C. difficile infections and
drug interactions and side effects are the most common complications associated with
antibiotic use/overuse. Antibiotics are the second most common drug class associated
with adverse drug events among older adults in the ambulatory setting (15%), after
cardiovascular agents (26%), and carry double the risk associated with anticoagulant
medications (7.9%).9
Antibiotic resistance is considered a global threat caused by antibiotic overuse or
misuse. It happens when bacteria develop a way to overcome the medication that is
intended to kill them.10 The older adult population is at higher risk of antibiotic use,
immune system impairment and multiple chronic health conditions which could lead to
antibiotic resistance compared to other age groups.11,12,13 The Centers for Disease
Control and Prevention (CDC) reported that 2 million people each year are diagnosed
with infections caused by antibiotic-resistant bacteria. In addition, 23,000 people die
each year in the U.S. due to antibiotic resistance.10 In 2015, the U.S. White House
released a national action plan to defeat antibiotic resistance through developing
innovative prevention strategies, enhancing surveillance, and implementing
antimicrobial stewardship programs.14
Another complication due to antibiotic use/overuse is Clostridioides difficile (C. diff)
Infection (CDI). C. diff is a gram-positive, anaerobic bacillus that is often associated with
severe diarrhea and abdominal cramping. The CDC estimated in a recent report that
each year there are 500,000 CDI cases in the U.S., with 15,000 deaths attributable to
CDI annually.15 CDI costs the U.S. health care system up to 4.8 billion each year. The
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rate of CDI has increased dramatically in recent years, specifically among the older
adult population. Ninety-three percent of deaths attributable to CDI occur in older adults,
making it the 18th leading cause of death in the United States among older adults. 16
Prior antibiotic use, recent hospitalization, proton pump inhibitors use and a weakened
immune system are risk factors of CDI in older adults.17,18,19 As with antibiotic
resistance, the U.S. is working on a national plan to combat antibiotic resistant and
reduce the rate by 50% by 2020. One major element of this program is antimicrobial
stewardship programs.
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Antibiotic Stewardship Programs (ASPs):
Antibiotic stewardship programs aim to improve antibiotic use and reduce the number
of inappropriate antibiotic prescriptions, antibiotic resistance, side effects associated
with antibiotic use, and CDI. The program should help health care providers and
hospitals optimize antibiotic therapy. Progress in ASPs has primarily been in the acute
care setting. Effective on January 2017, the Joint Commission approved and released
the new antimicrobial stewardship standard, which requires all hospitals, critical access
hospitals, nursing homes, ambulatory care organizations, and office-based surgery
practices to implement ASP in their settings.20 As a result, during the time frame when
we conducted our studies, it was not mandatory for health systems to have an ASP for
outpatient settings.
According to the CDC, a successful ASP is based on seven key elements including
leadership commitment, accountability, medication expertise, action, tracking, reporting
and education.21 Table 1 shows the detail for each element.
Table 1.2. The CDC’s essential core elements for antibiotic stewardship programs
Key Element
Leadership commitment
Accountability
Medication expertise
Action
Tracking
Reporting
Education

Explanation
Hospitals should invest money, clinicians, IT support, nurses, and
pharmacists to implement ASP.
Hospitals should appoint a single leader who will be responsible for
program outcomes.
Hospital should appoint a pharmacist to lead and support the
appropriate antibiotic prescribing.
Hospitals should design a systematic approach to evaluate
patient’s needs for antibiotic.
Hospitals are responsible to track antibiotic prescriptions and
antibiotic resistance.
Hospitals should report the trend and the patterns of the negative
outcomes related to antibiotic misuse.
Hospitals should offer educational sessions to all health care
providers regarding antibiotic use, side effect, resistance, and CDI.
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Although many studies support the necessity of ASPs, other studies have shown
little effect from implementing ASPs. The success of ASPs may depend on including all
of the seven elements that we have mentioned in Table 1. ASPs have been projected to
mitigate 619,000 infections associated with antibiotic resistance.22 In addition, it is been
estimated that implementing ASPs in acute care would save approximately $7.7 billion
in direct medical costs. Although ASPs have been implemented in acute care for 30
years or more, they are still not required in most other health care settings including
outpatient settings where most older patients receive care. The Centers for Medicare &
Medicaid Services (CMS) announced that by November 2019, most long term care
settings (nursing homes) will be required to implement ASPs.
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The Older Adult Population:
Older adult is a term referring to a person who is 65 years or older. Today, there are
almost 40 million persons aged 65 years and older living in the U.S., and this number is
expected to increase to 89 million persons in the next 30 years.23 This rapid change in
population characteristics can lead to economic, social, and health care consequences,
especially if the healthcare system does not prepare for this change. Many older adults
have multiple comorbidities and receive more than one prescription medication, which
may lead to difficulty in managing their health and maintaining their quality of life. Also,
older adults experience physiologic changes associated with aging affecting their liver
and kidney function and immune system which may necessitate more individualized
dosing adjustment for antibiotics compared to other age groups.24

Figure 1.1. U.S. Population Ages 65 and Older, 1950 to 2050.25
10

Human beings experience normal changes during the aging process and these
changes are categorized as biological, psychological, and sociological. The most critical
changes contributing to an increased risk of infection in older age are the physiological
changes in the immune system. It is well established that the immune system response
to pathogens declines with age. In nonspecific immunity, the number of leukocytes
decreases with age. In humoral immunity, the level of isoagglutinins in the blood
declines in the older population. Also, the antibody response to the influenza vaccine
decreases in the older population. Moreover, as we age the capacity for mounting a
cell-mediated immune response declines.25 In addition, there are several biological
changes responsible for increasing the chance of infections in older adults including
changes in skin and mucosal barriers as a first line defense in the immune system.
During the aging process, skin becomes thinner and skin elasticity is weaker. Some
observations showed that the atrophy and drying of the skin were responsible for
endocarditis.26 Also, blood flow to the skin decreases as we age, which increases the
likelihood of chronic pressure ulcers. The rate of urinary tract infections (UTIs) is higher
among older adults. The biological changes in the excretion system may play an
essential role including decreased plasma flow through the kidney by 50% and
decreased glomerular filtration rate by 30%, which likely contribute to the development
of UTIs. Another physiological change as we age is the weakness of the muscles
around the bladder, consequently the bladder accumulates urine and emptying the
bladder becomes more difficult, which increases the risk of a urinary tract infection.
Older adults are at higher risk of using urinary catheters, especially in long-term care
facilities and this may also increase the risk of urinary tract infections in both genders.
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Most nursing home residents are at higher risk of infections especially UTI and URI due
to frailty, intubation, catheterization, physical dependence, cognitive impairment and
altered host resistance.27 However, the diagnosis of infection in older adult patients is
not always obvious and simple. The symptoms of infections in the older patient is
different than a younger patient and may not include fever that most of the health care
providers rely on to make a clinical decision of infection.11 This is because of the
physiological changes in temperature regulation due to normal aging.28 It is expected
that older adult patients present with infection without having a fever as well. 28 On the
other hand, taking patient history is an important element for an accurate diagnosis.
This is an issue with cognitively impaired patients. In addition, the symptom of delirium
may have many underlying causes including UTI which makes it difficult for the
physician to reach on accurate diagnosis.29,13 Physicians should be careful when
initiating an antibiotic prescription to an older adult patient.
These physiological changes that occur during aging are not only contributing to an
increased risk of infection, they also affect the response to antibiotics. As part of normal
physiological changes as we age, several organ functions important for eliminating
antibiotics from the body, including kidney function and liver function, decline. 30 Altered
drug elimination may necessitate lower doses of antibiotics in older adults to avoid
undesirable side effects or lower rate of clinical outcomes from the antibiotic.
Another common issues regarding antibiotic use among older adult population are
adverse drug reactions and drug-drug interactions. Previous studies have demonstrated
a positive relationship between adverse drug reactions and increasing age.31 It has
been reported to increase the odds of hospital admission and health care cost. 31 The
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common reported adverse drug reactions among older adults are anaphylaxis or allergic
reaction, Q-T prolongation, nephrotoxicity, and ototoxicity.32 On the other hand, older
adult patients at increased risk of drug-drug interactions due to polypharmacy,
comorbidities, and altered physiological functions due to aging.33

Geriatrics Clinic and Adult Internal Medicine Ambulatory Clinic at VCU Health:
The Geriatrics clinic (GC) at VCU Health, under the internal medicine clinics
structure, has been active for more than 30 years when it was founded by Dr. Peter
Boling. Dr. Boling had the passion and initiative to establish the GC to provide
specialized care to complex and vulnerable older adult patients. Due to an increase in
the number of complex patients being cared for at VCU Health, the Geriatrics clinic
became a separate clinic from the Adult Internal Medicine Clinic starting in January
2012. All of the physicians serving the patients in the GC are geriatricians, and the
nurse practitioners are either adult-gerontology or family medicine specialists. The
overall goal of the GC is to provide comprehensive care for older adults (65 years or
older) who have complex needs like polypharmacy and multiple chronic conditions. In
comparison with older adult patients visiting the Adult Internal Medicine clinic, the GC
patients are considered sicker and more complex patients regarding medications and
the number of medical conditions according to Martha Purvis, an experienced nurse
practitioner at the GC. A recent statistic shows that the GC provides care to over 500
patients per provider annually.
On the other hand, the Adult Internal Medicine clinic has been providing care for older
adult patients at VCU Health since 1838. The Department of Internal Medicine at VCU
Health consists of more than 180 clinicians, 124 residents under training, and over 80
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fellows. There are ten divisions under the department of internal medicine, which
includes Cardiology, Endocrinology, Gastroenterology, General Internal Medicine,
Geriatrics, Hematology, Infectious Diseases, Nephrology, Pulmonary diseases, and
Rheumatology.
In one of the studies presented in this dissertation (Study Two), we used data from
2012-2017 from the Geriatrics clinic, and the Adult Internal Medicine clinic.
Antibiotic Appropriateness:
Antibiotic inappropriateness could lead to increased risk of antibiotic resistance, C.diff
infection and preventable adverse drug reactions. Antibiotic inappropriate is defined as
“Use of antimicrobials in the setting of established infection to which the pathogen is
resistant or use of antimicrobials not recommended in treatment guidelines.” 34 There are
different definitions of assessing antibiotic appropriateness in epidemiological studies.
Most of them have used subjective measures based on expert opinion-based
definitions. These opinions are usually based on treatment guidelines for specific
infections, dosage adjustment, medication route, or duration of therapy. In our studies,
we have used a validated method developed by Fleming-Dutra et al.8 This study used a
comprehensive methodology with a team of experts systematically reviewing the
national guidelines for antibiotic use for common infectious diseases among the older
adult population. The criteria for antibiotic appropriateness that we have used in our
studies was based on diagnoses and treatment guidelines. This method was
appropriate for our studies due to availability of the variables that we need to assess
antibiotic appropriateness. For instance, we lack the medication dose, or duration of
therapy variables, that is why we didn’t evaluate the appropriateness based on either
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dose or duration of therapy. Despite the limitation of our method, expert opinion-based
evaluations are commonly used in epidemiological studies.
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Rational (Significance):
A nationally representative study in the U.S. demonstrated significant increases in
broad-spectrum antibiotic use among the older adult population from 2000 to 2010. 5 In
2000, the antibiotic use was about 287 prescriptions per 1,000 persons, and this
number doubled by 2010 to 482 prescriptions per 1,000 persons. The most commonly
prescribed antibiotics vary and depend on the guidelines of the treatment in specific
countries. For instance, in the U.S. and Canada, quinolones were the most commonly
prescribed antibiotics for urinary tract infections (UTI),35,36 while in Australia, doxycycline
was the most widely prescribed antibiotic for UTI and respiratory infections.37 The term
“older adult” that was used in these studies referred to a person who was 65 years or
older. Today, there are almost 40 million persons aged 65 years and older living in the
U.S., and this number is expected to increase to 89 million persons in the next 40
years.38 This rapid change in population characteristics can lead to economic, social,
and health care consequences, especially if the healthcare system does not prepare for
this change.

The two major threats of antibiotic overprescribing are antibiotic resistance and
increased CDI incidence rate. These threats have received significant focus at the
international level from organizations like the World Health Organization (WHO) and at
the national level in the U.S. from organizations like the White House initiative to combat
antibiotic resistance.39 As a result of our studies, we seek to add valuable information to
the literature in order to better understand antibiotic use among the older adult
population. This information is currently limited in the literature, and comparing our
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results with the previous studies within the same scope would be helpful to understand
antibiotic use among older adults. There is limited information regarding this issue within
the older adult population due to lack of accessible data to facilitate this kind of study.
We are aiming that the results of our studies will help to uncover needs that might be
addressed through antibiotic stewardship programs and the consequences of antibiotic
misuse among older adults.
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Specific Aims:
This dissertation project is comprised of three different studies that are related to
antibiotic use among the older adult population using national and local data sources.
The objectives of each study are listed below.

Study 1: The Trend of Antibiotic Use Among Community-Dwelling Older Adults in
The United States (Medical Expenditure Panel Survey MEPS 2011-2015).
The specific aims are:
1) To understand the patterns of antibiotic use among non-institutionalized
community-dwelling older adults using Medical Expenditure Panel Survey MEPS
from 2011-2015.
2) To describe the patterns of the most common infectious diseases among noninstitutionalized community-dwelling older adults using Medical Expenditure
Panel Survey MEPS from 2011-2015.
3) To understand the association between antibiotic use and demographic,
socioeconomic characteristics and emergency department visits.

Study 2: A Comparison of Antibiotic Use and Infectious Diseases Among Older
Adults between Geriatrics Clinic and Adult Internal Medicine Ambulatory Care
Clinic in VCU Health.
The specific aims are:
1. To assess the trend of antibiotic use and infectious diseases among Geriatrics
clinic patients at VCU Health from 2012-2017.
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1A) To assess the most common antibiotics prescribed for the three most
common infectious diseases: urinary tract infection (UTI), upper respiratory tract
infection (URI), and skin infection.
2. To assess the trend of antibiotic use and infectious diseases among older adult
patients visiting adult internal medicine ambulatory care clinic at VCU Health
from 2012-2017.
2A) To assess the most common antibiotics prescribed for the three most
common infectious diseases: urinary tract infection (UTI), upper
respiratory tract infection (URI), and skin infection.
3. To compare the antibiotic appropriateness between the Geriatrics clinic and Adult
Internal Medicine Ambulatory clinic at VCU Health from 2012-2017.
4. To assess the relationship between the antibiotic appropriateness and
demographic, socio-demographic characteristics, type of clinic, antibiotic
negative outcomes like emergency department visit or hospitalization within 30
days after the initiation of antibiotics.

Study 3: Antibiotic Use Among Older Adults Visiting The Emergency Department
(ED) at VCU Health 2012-2017.
The specific aims are:
1. To assess the trend of antibiotic use and infectious diseases among older adult
patients (65 years or older) visiting the ED at VCU Health from 2012-2017.
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1A) To assess the most common antibiotics prescribed for the three most
common infectious diseases: urinary tract infection (UTI), upper respiratory tract
infection (URI), and skin infection.
2. To assess the trend of antibiotic use and infectious diseases among middle-aged
patients (55 to 64 years old) visiting the ED at VCU Health from 2012-2017.
2A) To assess the most common antibiotics prescribed for the three most
common infectious diseases: urinary tract infection (UTI), upper
respiratory tract infection (URI), and skin infection.
3. To compare the antibiotic appropriateness between older adult patients and
middle-aged patients visiting the ED at VCU Health from 2012-2017.
4. To assess the relationship between antibiotic appropriateness and demographic,
socio-demographic characteristics, age group, antibiotic negative outcomes like
ED visit or hospitalization within 30 days after the initiation of antibiotics.
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Summary:
This dissertation contains five chapters. The first chapter is the introductory chapter,
which provides an overview of antibiotic use, and its complications among older adults.
In addition, the first chapter describes the aging population in the U.S. and the rational
and specific aims for each study. The second chapter details the first study, which aims
to answer questions related to antibiotic use among non-institutionalized older adults in
the U.S. using nationally representative data. The third chapter describes a study
examining the issue of antibiotic appropriateness and compares the patterns of
antibiotic use and infectious diseases between Geriatrics clinic patients vs. adult
Internal Medicine Ambulatory clinic at VCU Health from 2012-2017. The fourth chapter
describes the results of the final study, which examined antibiotic appropriateness
among older adults visiting the ED at VCU Health from 2012-2017. The final chapter is
the discussion chapter, which describes the main findings, draws overarching
conclusions and discussed the implications of the work and future directions.
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CHAPTER TWO

Study 1: The Trend of Antibiotic Use Among Community-Dwelling Older Adults in
The United States (Medical Expenditure Panel Survey MEPS 2011-2015)

27

Background:
It has been well documented that antibiotic overuse/misuse increases the risk of
Clostridioides difficile (C.diff) infection as well as antibiotic resistance.1,2 The Centers for
Disease Control and Prevention (CDC) has reported that 23,000 people die each year
due to antibiotic resistant infections.2 Older adult populations are growing globally and in
the United State (US) specifically. It was estimated that the adult population aged 65 or
older will grow to around 89 million people by 2050 in the US, more than double the
number of older adults in 2010.3 This specific population has unique characteristics that
need more attention in terms of health care improvement. Older adult patients are more
likely to have comorbidities, polypharmacy, and changes in kidney and liver function
that could affect the pharmacokinetics and other responses to antibiotics. 4,5
Antibiotic overuse leads to significant increase in the emergency department
visits associated with adverse drug reactions.6 Older adults aged 65 and older are at
increased risk of adverse outcomes from antibiotics and other drug classes like
anticoagulants and antidiabetic medications.7 Despite the extensive efforts from the
CDC, US government, and the health care system to reduce antibiotic prescribing
through implementing antimicrobial stewardship programs8 among all ages, antibiotic
prescription rates increased 30% among older adults from 2000 to 2010, while the
antibiotics rate decreased among children and adolescents.9
In addition, it is important to understand prescribing practices among older adults
from a nationally representative perspective to inform health care initiatives to improve
antibiotic use and reduce the negative outcomes related to antibiotic misuse like allergic
reactions, drug-drug interactions, and C.diff infections. Therefore, the first objective of
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this study was to understand the patterns of antibiotic use among community-dwelling
older adults in the US using the Medical Expenditure Panel Survey (MEPS), a nationally
representative database from 2011-2015. The second objective was to document the
most common infectious diseases in the same population. The third objective was to
understand the association between antibiotic use and demographic characteristics,
socioeconomic characteristics and emergency department utilization.
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Methods:
Data Source:
A cross-sectional retrospective study was conducted to assess the patterns of
antibiotic use among community-dwelling older adults using MEPS 2011-2015. The
most recent MEPS database available was used in this study. MEPS is collected by the
Agency for Healthcare Research and Quality (AHRQ).10 MEPS is a publicly available
nationally representative database that surveys non-institutional families and
individuals, and their medical providers across the US. The data includes only deidentified patient characteristics and pharmacy claims. MEPS uses a complex stratified
multistage cluster design technique during the survey collection, which allows
researchers to calculate national weighted estimates. In addition, all the information in
the patient full-year consolidated data files, medical conditions files, prescribed
medicine files, and emergency room files were used in the analysis.
Study Sample:
Only individuals 65 years and older were included in this analysis. From the fullyear consolidated file, we obtained age, gender, race, marital status, level of education,
health status, flu vaccination status, annual family income, and health insurance status.
We collected antibiotic prescriptions dispensed and prescribed proton pump inhibitor
use from the prescriptions file. In MEPS data, participants reported the list of
medications and were asked for permission to look at their pharmacy data as well. From
the emergency file, we obtained the number of ER visits in the past 30 days. Infectious
disease diagnoses were obtained from the medical conditions file and identified using
the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-
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CM). Upper respiratory tract infections (URI) were included using the following ICD-9Codes: 041, 460, 461, 462, 463, 464, 465, 466, 486, and 490. ICD-9-Code 599 was
used for urinary tract infection (UTI). Skin and soft tissue infections were included using
ICD-9-Codes 681, 682, 686, 690, 691, and 691. ICD-9-Codes 008 and 009 were used
to define any intestinal infections, while 486 was used to define pneumonia cases. Any
participants younger than 65 years of age or with incomplete information regarding
antibiotic use were excluded.
Statistical Analysis:
Descriptive analysis was used to calculate the weighted frequency and
percentage for the categorical variables in both antibiotic users and non-users. A chisquare test was used to test the association between the covariates and the outcome of
interest (antibiotic use). Trend analysis was performed using the Cochran–Armitage
test. U.S. Census data were used to calculate the rate of infectious diseases and
antibiotic prescriptions per 10,000 population.11 A multiple logistic regression model was
used to test the association between antibiotic use and demographic characteristics,
geographic region, socioeconomic characteristics and emergency department use. Any
variable that maintained a p-value of 0.1 was included in the multiple logistic regression
model. We have used the MEPS person weights, sampling variance estimation strata
for each year in order to calculate a nationally weighted estimate. A p-value less than
0.05 was considered statistically significant. All the statistical analyses were conducted
using SAS software version 9.4 (SAS Institute, Inc., Cary, NC).
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Ethical Considerations:
This study was deemed as an exempt study by the Virginia Commonwealth
University Institutional Review Board (VCU IRB #HM20013520).
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Results:
In our study, there were 105,762,134 prescriptions dispensed to older adults in
the outpatient settings in the US from 2011 to 2015. The overall rate of antibiotic
prescriptions dispensed increased slightly, from 484 prescriptions per 1,000 persons in
2011 to 540 prescriptions per 1,000 persons in 2015. Prescribing rates decreased with
age, the oldest-old participants (80 years or older) reported lower prescriptions than 6569 year olds, 7% and 11% respectively (Table 2.1). Antibiotic prescriptions were more
common among women (18%) compared to men (12%). White participants received
more antibiotics (27%) than African Americans (1.77%) and others (1.4%). Eight
percent of older adults who received antibiotic prescriptions reported that they visited
the emergency department at least once in the study period (2011-2015).
Multiple logistic regression modeling shows that the 75-79 years age group are
41% more likely to receive antibiotics compared to the oldest-old group (80 or older)
(Table 2.2). Females were significantly (52%) more likely to receive antibiotics
compared to men. Moreover, ER visits were significantly associated with antibiotic
prescriptions; older adults visiting the ER were two times more likely to receive and
antibiotic compared to non-ER visitors. Proton-pump inhibitors PPI users were not
associated with antibiotic dispensing compared to non-antibiotic users.
URI, UTI, and skin infections were the most common infectious diseases
documented in our study population. The rate of URI increased over time from 135
infections per 1,000 persons in 2011 to 166 infections per 1,000 persons in 2015
(Figure 2.1). The same trend was observed in UTI infections which increased from 55 to
75 infections per 1,000 persons between 2011 and 2015. Macrolides, quinolones, and
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penicillins were the most common antibiotic categories prescribed to older adults from
2011 to 2015. The rate of use of penicillins increased over the study period from 169
prescriptions per 1,000 prescriptions to 256 prescriptions per 1,000 prescriptions,
accounting for 21% of all antibiotic prescriptions. Quinolone prescription rates were
stable while macrolide prescription rates dropped from 334 to 156 prescriptions per
1,000 prescriptions, accounting for 26% of all antibiotic prescriptions (Figure 2.2).
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Table 2.1. The demographic characteristics of antibiotic users and non-users in MEPS from
2011-2015.
Variable

Antibiotic Use (Yes)
Sample
persons

Age (years)
65-69
70-47
75-79
80 or older
Sex
Male
Female
Race
White
African American
Other
Marital status
Married
Other
Education
No education
High school or less
College years
Health status
Excellent
Very good
Good or fair
Poor
Flu vaccine
Yes
No
Family income
Poor or near poor
Low income
Middle income
High income
Insurance
Private
Medicaid
Medicare
ER visit
No visit
1 to 3 visits
4 or more visits
PPI prescribed
Yes
No

Weighted %, [95% CI]

Antibiotic Use (No)
Sample
persons

Weighted %, [95% CI]

1844
1182
891
1110

10.59 [9.77- 11.40]
7.40 [6.88-7.91]
5.60 [5.10-6.09]
6.99 [6.31-7.67]

4286
3053
2317
3438

21.78 [20.80-22.77]
16.38 [15.51-17.26]
12.41 [11.64-13.18]
18.82 [17.59-20.05]

1927
3100

12.17 [11.50-12.85]
18.41 [17.64-19.17]

5829
7265

31.98 [30.96-33.00]
37.42 [36.45-38.38]

3996
658
373

27.41 [26-24-28.58]
1.77 [1.51-2.02]
1.40 [1.09-1.71]

9004
2730
1360

58.00 [56.55-59.45]
6.90 [6.00-7.80]
4.49 [3.44-5.53]

2598
2429

17.31 [16.27-18.34]
13.27 [12.52-14.02]

6541
6553

37.88 [36.45-39.30]
31.53 [30.04-33.01]

12
1148
617

0.13 [0.01-0.25]
19.26 [17.66-20.86]
11.85 [10.69-13.01]

40
2997
1589

0.28 [0.14-0.41]
40.86 [38.99-42.74]
27.59 [25.62-29.57]

649
1380
2585
347

4.79 [4.31-5.27]
9.04 [8.41-9.67]
14.90 [14.06-15.74]
1.87 1.60-2.13]

1778
3563
6797
770

11.16 [10.37-11.95]
21.48 [20.67-22.30]
33.26 32.21-34.30]
3.46 [3.09-3.84]

890
242

24.20 [22.28-26.11]
6.15 [5.09-7.20]

2214
858

51.13 [48.58-53.68]
18.51 [16.72-20.30]

1411
1268
1071
1180

6.85 [6.28-7.43]
7.67 [7.10-8.24]
7.19 [6.59-7.79]
8.94 [8.12-9.76]

4084
3381
2767
2513

17.25 [16.20-18.30]
18.56 [17.53-19.60]
16.35 [15.40-17.30]
17.14 [15.82-18.46]

1740
3207
26

12.11 [11.26-12.97]
18.49 [17.63-19.36]
0.06 [0.03-0.10]

3848
8914
103

25.09 [23.92-26.26]
43.89 [42.64-45.14]
0.32 [0.17-0.48]

3555
1389
83

21.97 [21.09-22.85]
8.18 [7.61-8.75]
0.43 [0.32-0.53]

10800
2225
69

57.55 [56.47-58.63]
11.48 [10.81-12.15]
0.36 [0.24-0.49]

1285
3742

7.77 [7.16-8.39]
22.80 [21.91-23.70]

2629
10465

13.67 [12.86-14.47]
55.74 [54.57-56.91]

35

Table 2.2. Multiple logistic regression analysis predicting antibiotic users vs. non-users
Variable
Age (years)
80 or older
65-69
70-47
75-79
Sex
Male
Female
Race
White
African American
Other
Marital status
Other
Married
Education
College years
No education
High school or less
Health status
Good or fair
Excellent
Very good
Poor
Flu vaccine
No
Yes
Family income
High income
Poor or near poor
Low income
Middle income
Insurance
Medicare
Private
Medicaid
ER visit
No Visit
1 to 3 visits
4 or more visits
PPI prescribed
No
Yes

Unadjusted or [95% CI]

Adjusted or [95% CI]

1 [Reference]
1.30 [1.13-1.50] *
1.21 [1.07-1.38] *
1.21 [1.04-1.40] *

1 [Reference]
1.19 [0.66-2.13]
1.36 [0.80-2.29]
1.41 [0.81-2.44]

1 [Reference]
1.29 [1.18-1.40]*

1 [Reference]
1.52 [1.10-2.10] *

1 [Reference]
0.54 [0.47-0.62] *
0.66 [0.54-0.79] *

1 [Reference]
0.69 [0.43-1.10]
1.20 [0.70-2.08]

1 [Reference]
1.08 [0.98-1.19]

1 [Reference]
1.17 [0.86-1.59]

1 [Reference]
1.10[0.41-2.95]
1.09[0.95-1.26]

1 [Reference]
0.73 [0.26-2.01]
1.43 [1.00-2.04] *

1 [Reference]
0.95 [0.84-1.09]
0.93 [0.85-1.03]
1.20 [0.99-1.46]

1 [Reference]
0.96[0.53-1.76]
0.93 [0.66-1.32]
1.23[0.72-2.09]

1 [Reference]
1.42 [1.15-1.75] *

1 [Reference]
1.12 [0.79-1.59]

1 [Reference]
0.76 [0.68-0.85] *
0.79 [0.70-0.88] *
0.84 [0.74-0.95] *

1 [Reference]
0.49 [0.29-0.84] *
0.60 [0.37-0.98] *
0.54 [0.33-0.89] *

1 [Reference]
1.14[1.04-1.25] *
0.50[0.28-0.90] *

1 [Reference]
1.09 [0.77-1.55]
1.01[0.27-3.80]

1 [Reference]
1.86 [1.69-2.05] *
3.06 [2.02-4.63] *

1 [Reference]
2.03 [1.42-2.89] *
0.08 [0.00-1.04]

1 [Reference]
1.39 [1.26-1.53] *

1 [Reference]
1.10 [0.76-1.58]
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The Trend of Infectious Diseases Among Older Adults using MEPS
2011-2015
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Figure 2.1. The trend of infectious diseases among older adults using MEPS 20112015.
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Antibiotic Prescriptions Rate per 1000 prescriptions among older
adults using MEPS 2011-2015
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Figure 2.2. The rate of antibiotic prescriptions per 1000 prescriptions among older
adults using MEPS 2011-2015.
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Discussion:
This study assessed the prevalence of antibiotic prescriptions dispensed among
community-dwelling older adults in the US using MEPS 2011-2015 data. In addition, this
study assessed the rate of infectious diseases and the predictors of antibiotic users
compared to non-users. Several studies have reported the rate antibiotic use in different
time periods, age groups, and data sources, but this study specifically focused on the
older adult population. Older adults are at high risk of polypharmacy, drug-drug
interactions, adverse drug reactions, comorbidities as well as age-associated
physiological and changes that affect the pharmacokinetics and pharmacodynamics of
medications. Antibiotic use in this population has rarely been reported in the literature
and antibiotic prescribing practices are not clear. Based on our results, 31% of the noninstitutional older adults in the US were prescribed antibiotics, accounting for
105,762,134 prescriptions over the study period. We estimate that the antibiotic
prescribing rate increased slightly from 483 to 540 prescriptions per 1,000 persons. A
similar rate was observed in 2010 by Lee et al., using the early rounds of MEPS data
suggesting that the rate has been relatively stable since 2010. 9 This unchanged rate
since 2010 could be explained by several reasons. First, the effort of implementing
antibiotic stewardship programs (ASPs) is not strong enough to cover a wide range of
settings in the health care system, like ambulatory care clinics, assisted living facilities,
and pharmacies. A study estimated that 30% of outpatient antibiotics were inappropriate
among all ages.12 Therefore it is crucial to implement ASPs in outpatient settings in
addition to inpatient settings. Second, there could be a lack of knowledge among some
health care providers about ASPs instituted by institutions where they practice. A study
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found that 25% of nurses at VCU-HS were not aware that ASPs existed at VCU
Health.13 Education is also important to family members who have a significant impact
on antibiotic prescribing among older adult populations.14,15,16
We have found that in 2015, the antibiotic prescribing rate was 540 prescriptions
per 1,000 persons, and this estimate is lower than the rate of antibiotic prescribing
reported in a study conducted by Olesen et al., using data from Medicare beneficiaries
enrolled Medicare Part D.17 They found that the rate of antibiotic prescriptions in 2015
was 1,364.3 per 1,000 persons. This difference could be related to the differences in the
data sources. MEPS does not include nursing home patients or any institutionalized
patients, unlike Medicare Part D data. We found that older adults aged 65-69 years
were more likely to be prescribed an antibiotic than the oldest-old participants. This
observation could be related to increasing complexity with age resulting in health care
providers avoiding adding extra medications that could lead to an emergency visit or
hospitalization. Evaluating the antibiotic appropriateness among older adult populations
is necessary for future research.
In addition, this study found that URI was on the most common infectious
disease among older adults followed by urinary tract infections and skin and soft tissue
infections. The rate for these diseases was relatively stable from 2011-2015. Similar
results were found by Tan et al., when they conducted a similar study among older
adults in Canada using The Ontario Drug Benefit Program database.18 Although the two
databases could be different in nature, the population of older adults studied shared
common characteristics.
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Macrolides, quinolones, and penicillins were the most common antibiotic classes
dispensed to older adults in the US from 2011-2015. In the Olesen et al. study,
quinolones were most commonly prescribed, followed by macrolides and penicillins. 17 In
our study, we had a higher rate of URI treated by macrolides than rates observed in the
other study. We observed that macrolide prescriptions deceased since 2013, while the
rate of penicillins increased over the study period. This could be due to shifting practice
from prescribing macrolides to pencillins due to reports of cases of severe toxicity and
death related to macrolide use.19
This study has several limitations. First, although we have used nationally
representative data, using MEPS specifically could raise a selection bias limitation.
MEPS uses self-reported surveys among active members of the society which leads to
selection bias. Also, using MEPS data could underestimate capturing the acute
diseases like infectious diseases. Second, in order to assess the rate of infectious
diseases, we used ICD-9-Codes for the primary diagnosis of each participant. This
method could underestimate the antibiotic rate because not all antibiotic prescriptions
were prescribed for the primary diagnosis. Third, some of the variables including
emergency department visits, health status, and annual income were obtained through
a survey methodology which is subject to potential recall bias. Fourth, in our analysis for
the antibiotic indications, we have used ICD-9-Codes for the entire study period, while
ICD-10-Codes came into use in mid-2015, so there a potential that we have
underestimated some of the indications in 2015.
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Conclusions:
In conclusion, the rate of antibiotic use overall remains unchanged despite
antimicrobial stewardship efforts. The changes in the patterns of use in some of the
antibiotic categories appear to be driven more by safety concerns rather than reducing
overall use. Future research is needed to strengthen antibiotic stewardship programs for
older adults in outpatient settings.
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CHAPTER THREE

Study 2: A Comparison of Antibiotic Use and Infectious Diseases Among Older
Adult Patients of VCU Health’s Geriatrics and Internal Medicine Ambulatory Care
Clinics
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Background:
Antibiotic resistance is a global threat following antibiotic use.1,2,3,4 Several
reports have documented that the mortality rate due to antibiotic resistant infections is
projected to reach 10 million per year by the year 2050 with an estimated health care
cost burden of 100 trillion dollars per year by 2050.1 Studies suggest that antibiotic
overprescribing and misuse increases antibiotic resistance and Clostridioides difficile
(C.diff) infection. 51.6 million prescriptions (1,115 prescriptions/1,000 persons) were
written in 2014 for older adult outpatients in the United States according to a recent
report.5 A nationally representative study demonstrated significant increases in broadspectrum antibiotic use among the older adult population from 2000 to 2010. In 2000,
antibiotic use was about 287 prescriptions per 1,000 persons, and this number doubled
by 2010 to 482 prescriptions per 1,000 persons. In the same study, the rate of antibiotic
prescriptions decreased from 2000-2010 among children and adolescence and
increased about 30% among older adults.6
The older adult population in the United States is projected to increase by 20% by
2030 according to a recent Centers for Disease Control and Prevention (CDC) report.7
This population is more prone to use antibiotic medications than any other age group
due to decreased immune function, use of urinary catheters, ventilation during
hospitalization and other factors.8,9,10 In 2010 study, older adults reported the highest
antibiotic use rate compare to younger adults in the US.11 In addition, older adults are
more susceptible to adverse drug reactions including C.diff infections and drug-drug
interaction due to polypharmacy, comorbidities, and normal physiological changes like
changes in the liver and kidney functions.12,13,14 In 2015, The White House published
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the National Action Plan For Combating Antibiotic-Resistant Bacteria, which aspires to
achieve a major reduction in C.diff infections and Methicillin-Resistant Staphylococcus
aureus (MRSA) infections by 2020 by reducing inappropriate antibiotic prescriptions by
50%.3 It is crucial to understand antibiotic use patterns in different settings in the
healthcare system and among the older adult population in particular in order to meet
the White House goals.
The Geriatrics clinic at Virginia Commonwealth University (VCU) Health was
established to support the specific care needs of older adults in the outpatient setting,
but the pattern of antibiotic prescribing in this clinic compared to an adult Internal
Medicine clinic serving adults of all ages at VCU Health is unknown. Therefore, the
specific aims for this study were to:
1. Assess the trends of infectious diseases and antibiotic prescribing among
Geriatrics clinic patients at VCU Health from 2012-2017.
2. Assess the trends of infectious diseases and antibiotic prescribing among older
adult patients visiting adult Internal Medicine ambulatory care clinic at VCU Health
from 2012-2017.
3. Compare the antibiotic appropriateness between the Geriatrics clinic and the adult
Internal Medicine ambulatory care clinic at VCU Health from 2012-2017.
4. Assess the relationship between the antibiotic appropriateness and sociodemographic characteristics, type of clinic and negative outcomes associated with
antibiotic use including an emergency department visit hospitalization during the
30 days after the initiation of antibiotics.
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Methods:
Data Source:
We used electronic medical records data from the VCU Health Ambulatory Care
Center (ACC) for the geriatric clinic and the internal medicine clinic from 2012-2017.
The 2012 year was selected to start data collection because this was the founding year
for the geriatric clinic at VCU Health. The year 2017 was the most recent complete data
available at the time of data retrieval. VCU Health is an urban academic medical center
in central Virginia. The data was retrieved from the electronic medical records and
billing records by the Bioinformatics core of the VCU Center for Clinical and
Translational Research (CCTR).
Study Design and Sample Selection:
This is a cross-sectional retrospective cohort study of electronic medical records
of Geriatrics clinic and adult Internal Medicine ambulatory care clinic from 2012-2017.
Inclusion and Exclusion Criteria:
Only patients 65 years or older who received an antibiotic prescription during an
outpatient visit to either the Geriatrics clinic or adult Internal Medicine clinic at VCU
Health from 2012-2017 were included in this study. Only oral antibiotic prescriptions
were included in the study to avoid any inpatient antibiotic prescriptions. All patients
who received an antibiotic prescription within 2 days of hospital discharge were
excluded from the study to avoid any hospital related infections. All patients who
received an antibiotic prescription that was not prescribed on the day of clinic visit were
excluded from the study. Finally, any patient with missing information in the medication
file or diagnosis file were excluded from the study.
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Study Measures:
Demographic Characteristics:
Age, race, gender, marital status, and clinic visited were collected from VCU
Health electronic medical records from 2012-2017. Age was treated as categorical
variable in this study and categorized into 5 year intervals for the analysis (65-69, 70-74,
75-79, and 80 years and older). Patients older than 80 years were censored in the
oldest group to preserve patient confidentiality as required for an exempt study with the
VCU Institutional Review Board (IRB). The race variable was categorized as White,
African American, and other. The ‘other’ category in the race variable includes American
Indian/Alaskan, Asian, Native Hawaiian, and other. The gender variable was
categorized as male or female. Marital status was categorized as married, single, or
other (divorced, separated, or widowed). Type of clinic was a dichotomous variable
defined as Internal Medicine or Geriatrics clinic.
Outcomes Measures:
Infectious Disease Diagnoses:
The infectious disease diagnoses were identified by the International
Classification of Diseases ICD-9-CM code assigned to each patient during the
outpatient visit. VCU Health shifted to ICD-10-CM codes by end of 2015, so in our
analysis, we have used both ICD-9-CM and ICD-10-CM codes. In our study, we
included the most common infectious diseases among older adult patients visiting VCU
Health outpatient clinics, which included urinary tract infection, upper respiratory tract
infection, skin infection, pneumonia, C. diff. infection and otitis media. Table 3.1 details
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the ICD-9-CM and ICD-10-CM codes for each infectious diseases included in our
analyses.
Antibiotic Prescribing Patterns:
The trends of antibiotic prescribing over time was derived from the ‘anti-infective’
medication category in the medication files. The medication file was abstracted from the
electronic medical record and contains the medication name, category name, dosage
form, and medication dose. The medication file includes all of the antibiotic prescriptions
that every patient at VCU Health received over the study period in the two clinics that
we studied, so a patient could have multiple antibiotic prescriptions over the study
period. Our data has eleven antibiotic categories including macrolides (azithromycin,
erythromycin), quinolones (ciprofloxacin, levofloxacin), sulfonamides (sulfamethoxazoletrimethoprim), urinary anti-infectives (nitrofurantoin), penicillins/beta-lactamase inhibitors
( amoxicillin-clavulanate), miscellaneous antibiotics (metronidazole, rifaximin),
tetracyclines (tetracycline, doxycycline), first generation cephalosporins (cephalexin),
second generation cephalosporins (cefuroxime), third generation cephalosporins
(cefdinir, cefpodoxime), and aminopenicillins (amoxicillin). The antibiotic prescribing
trend was tested across all indications in each clinic and individually among the three
most common infectious diseases (urinary tract infection (UTI), upper respiratory tract
infection (URI) and skin infection) in the older adult population.
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Antibiotic Appropriateness:
To assess oral antibiotic appropriateness, we used a validated method that was
conducted by Fleming-Dutra et al.15 Fleming-Dutra et al, has developed this tool with
the help of a team of experts to review national guidelines for antibiotic use for the
common infectious diseases among outpatient clinics. The criteria categorized antibiotic
appropriateness into three different tiers based on the clinical diagnosis as follows:
1. Tier 1: Antibiotics almost always indicated: including UTI, C.diff. Infection and
pneumonia.
2. Tier 2: Antibiotics may be indicated: such as acute sinusitis, suppurative otitis
media, and some types of skin infections.
3. Tier 3: Antibiotics not indicated: including acute and chronic bronchitis,
influenza, some type of skin infection, and URI.
Table 3.2 lists the ICD-9-CM and ICD-10-CM codes for each tier in this analysis.
Statistical Analysis:
The demographic characteristics were summarized using descriptive statistics
(frequency/percentage). Chi-square tests were used to test the relationship between the
outcomes variables and the categorical demographic variables. To adjust for the clinic
visit variabilities, we calculated the antibiotic rate normalizing each year by the total
number of visits for each clinic separately. Trend analysis was performed using the
Cochran–Armitage test. Logistic regression modeling was performed after checking the
assumptions, and odds ratio and ninety-five percent confidence intervals were reported
for all estimates. Variables were included in the model if α equal to 0.1 and all variables
were considered statistically significant at an α level of 0.05. All the statistical analyses
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were conducted using the Statistical Analysis Software Version 9.4 (SAS v.9.4), (SAS
Institute Inc, Cary, NC).
Ethical Considerations:
The VCU IRB reviewed and approved this study as exempt (VCU IRB #:
HM20013584).
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Table 3.1. The ICD-9-CM and ICD-10-CM codes for each infectious diseases included
in the study.
Type of infection
Urinary tract infection
Upper respiratory tract
infection
Pneumonia
Skin infection
Otitis media
Clostridioides difficile
infection

ICD-9-CM or ICD-10-CM
'599' 'N39.0'
'478.9' '465.9' 'J06.9' '490' '491.21' '466' 'J20.9' 'J40' '491.9'
'461.9' 'J01.90' '473.9' 'J32.9' 'J01.00' '477.9' 'J30.9'
'486' 'Z87.01' 'J18.9' 'J18.8' '516.3' 'B96.1'
'682.6' '682.9' '682.6' '528.3' 'L03.90' 'L03.116' 'L03.115'
'H60.12'
'380.1' '381.1' 'H66.93' 'H66.92' 'H66.91' 'H66.90' '382.9'
'381.4'
'A04.7' '8.45'
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Table 3.2. Antibiotics appropriateness criteria according to Fleming-Dutra et al.15
Diagnosis
Corresponding ICD-9-CM or ICD-10-CM
Tier 1: Antibiotics almost always indicated:
Urinary tract infection (UTI)
'599' 'N39.0'
Bacterial pneumonia
'486' 'Z87.01' 'J18.9' 'J18.8' '516.3' 'B96.1'
Clostridioides difficile infection
'A04.7' '8.45'
Tier 2: Antibiotics may be indicated:
Acute sinusitis
Skin, cutaneous and mucosal
infections
Suppurative otitis media
Tier 3: Antibiotics not indicated:

'461.9' 'J01.90' '473.9' 'J32.9' 'J01.00'
'382.9' 'H66.90' 'L03.115' 'L03.116' 'L03.90'
'528.3' '682.6' '682.9' '682.6'
'H66.91' '380.1' '381.1' 'H66.93' 'H66.92'

Acute and chronic bronchitis,
bronchiolitis, allergic rhinitis
Non-suppurative otitis media
Viral upper respiratory infection (URI)

'490' '491.21' '466' 'J20.9' 'J40' '491.9' '477.9'
'J30.9'
'381.4'
'478.9' '465.9' 'J06.9'
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Results:
Among the 3,515 patients who visited either Geriatrics or Internal Medicine
ambulatory clinic from 2012-2017, 1,534 antibiotics were prescribed. Most of the
prescriptions (69%) were prescribed in the Internal Medicine ambulatory clinic
compared to. 31% of prescriptions initiated from the Geriatrics clinic. A majority of
Geriatrics clinic antibiotic recipients were 80 years and older (45%), female (77%), and
white or black (51% and 45%) respectively. In contrast, Internal Medicine ambulatory
clinic antibiotic recipients were more evenly distributed among the older adult age
categories. Demographic characteristics are presented in Table 3.3.
Antibiotic Appropriateness:
In our study, 43% of antibiotic prescriptions from the Geriatrics clinic were
considered potentially appropriate, while 50% were considered potentially appropriate in
the Internal Medicine ambulatory clinic. Potentially inappropriate antibiotic prescriptions
were similar between the two clinics (30% in Geriatrics clinic and 28% in Internal
Medicine ambulatory clinic) with p-value 0.08. Appropriateness of antibiotic prescribing
is presented in Table 3.4.
Infectious Diseases Trends:
Most of the antibiotics in our study were prescribed for six indications: UTI, URI,
pneumonia, skin infection, C. diff infection and otitis media. Among Internal Medicine
ambulatory clinic patients, the rate of UTI decreased from 32 diagnoses per 10,000
visits in 2012 to 23 diagnoses per 10,000 in 2017 compared to Geriatrics clinic patients
where the UTI rate dropped only slightly from 60 cases per 10,000 visits in 2012 to 56
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diagnoses per 10,000 visits. Skin infections were the most common infectious diseases
in 2017 in the Geriatrics clinic. The rate of skin infection in the Internal Medicine
ambulatory clinic dropped by half from 2012 to 2017 (10 vs. 5 diagnoses per 10,000
visits) respectively. On the other hand, the rate of skin infection increased in Geriatrics
clinic from 44 diagnosis per 10,000 visits to 76 diagnosis per 10,000 visits. Figure 3.1
presents the trend of infectious disease diagnoses from 2012 to 2017 in both clinics.
Antibiotic Prescribing Trends in Geriatrics Clinic Compared to Internal Medicine a
Ambulatory Clinic:
Quinolones, macrolides, and first generation cephalosporins were the most
common antibiotics prescribed in both clinics over the study period. The directionality of
the antibiotic rate between the two clinics remained the same from 2012 to 2017 in most
of the antibiotic categories. For instance, quinolone prescribing in the Geriatrics clinic
dropped from 179 prescriptions per 10,000 visits in 2012 to 106 prescriptions per
10,000 visits in 2017. The same pattern was seen in the Internal Medicine ambulatory
clinic where the quinolone prescribing dropped from 63 prescriptions per 10,000 visits in
2012 to 30 prescriptions per 10,000 visits in 2017. Likewise, first generation
cephalosporin prescribing in the Geriatrics clinic increased from 49 prescriptions per
10,000 visits in 2012 to 126 prescriptions per 10,000 visits in 2017. In the Internal
Medicine ambulatory clinic, first generation cephalosporin prescribing increased only
slightly from 15 to 20 prescriptions per 10,000 visits over the 5 year study period.
Moreover, third generation cephalosporin prescribing increased from 0 to 45
prescriptions per 10,000 visits among Geriatrics clinic patients, and the same rate was
observed among Internal Medicine ambulatory clinic patients (3 to 11 prescriptions per
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10,000 visits over the study period). The rates of prescribing for the eleven antibiotic
categories are shown in Figure 3.2.

Predictors of Receiving Potentially Inappropriate Antibiotics among Geriatrics
Clinic Compared to Internal Medicine Ambulatory Clinic:
Table 3.5 shows the results of multiple logistic regression modeling predicting
potentially inappropriate antibiotic prescriptions. This analysis showed that Internal
Medicine clinic providers are significantly (p-value <0.05) less likely to prescribe
potentially inappropriate antibiotics compared to the Geriatricians in the geriatric clinics
(OR=0.70 95% CI [0.54-0.90]. Age, gender, race, marital status, hospitalization within
30 days after an antibiotic prescription, emergency department visit within 30 days after
an antibiotic prescription were not significant predictors of receiving potentially
inappropriate antibiotics or potentially appropriate antibiotics.

Antibiotic Treatment for UTI, URI, and skin infections:
Among UTI patients in both clinics, quinolones and first generation
cephalosporins were the most common antibiotics prescribed over the study period
(Figure 3.3). In both clinics, the use of quinolones to treat UTI dropped over time from
81 to 18 prescriptions per 100 UTI patients in the Geriatric clinic, and from 66 to 36
prescriptions per 100 UTI patients in the Internal Medicine ambulatory clinic from 2012
to 2017. The rate of first generation cephalosporin prescribing remained the same over
time in the Geriatrics clinic, but increased from 15 to 33 prescriptions per 100 UTI
patients in the Internal Medicine ambulatory clinic.
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Macrolides, penicillins and quinolones were the most common antibiotic
categories prescribed to treat URI in both clinics in our study. The rate of macrolide
prescriptions increased in the Geriatrics clinic while the rate of quinolones and
penicillins slightly decreased or remained the same (Figure 3.4).
Finally, tetracyclines, first generation cephalosporins and penicillins were the
most common antibiotic categories prescribed to treat skin infection for patients in both
clinics. The rate of tetracycline prescribing dropped from 62 to 26 prescriptions per 100
skin infection diagnoses from 2012 to 2017 in the Geriatrics clinic. The same trend was
observed in the Internal Medicine ambulatory clinic where the rate of tetracycline
prescribing dropped from 58 to 50 prescriptions per 100 skin infections diagnosed. In
addition, the rate of first generation cephalosporin prescribing increased in the
Geriatrics clinic and the Internal Medicine ambulatory clinic from (50 to 66 and from 21
to 37 prescriptions per 100 skin infection diagnosis over the study period respectively)
(Figure 3.5).
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Table 3.3. Demographic characteristics among those who were prescribed antibiotics in
both ambulatory care clinics from 2012 to 2017
Factor (n=1534)

Age (years)
65-69
70-74
75-79
80 and over
Gender
Male
Female
Race
White
African American
Other
Marital Status
Married
Single
Other
Hospitalization Within 30
days after an Antibiotic
prescription
Yes
No
ER visit Within 30 days
after an Antibiotic
prescription
Yes
No

Geriatrics Clinic
(Freq/%)

Internal Medicine
Clinic
(Freq/%)

P-Value

<0.0001
94 (20.13)
96 (20.56)
67 (14.35)
210 (44.94)

384 (35.99)
245 (22.96)
229 (21.46)
209 (19.59)

106 (22.70)
361 (77.30)

255 (23.90)
812 (76.10)

0.6100

0.8582
242 (51.82)
212 (45.40)
13 (2.78)

556 (52.11)
476 (44.61)
35 (3.28)
<0.0001

113 (24.20)
59 (12.63)
295 (63.17)

364 (34.11)
527 (49.39)
176 (16.49)
0.8158

29 (6.21)
438 (93.79)

63 (5.90)
1004 (94.10)
0.0176

45 (9.64)
422 (90.64)

65 (6.09)
1002 (93.91)
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Table 3.4. Antibiotic appropriateness between Geriatrics clinic and Internal Medicine
ambulatory clinic.
Antibiotic appropriateness
(n=1534)

Geriatric Clinic
(Freq/%)

Antibiotics Almost always
indicated
Antibiotics maybe
indicated
Antibiotics not indicated

203 (43.47)

Internal Medicine
Clinic
(Freq/%)
527 (49.39)

125 (26.77)

243 (22.77)

139 (29.76)

297 (27.84)

P-Value

0.0830
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Table 3.5. Multiple logistic regression modeling assessing predictors of antibiotic
appropriateness among older adults visiting Geriatrics clinic and Internal Medicine
ambulatory clinic from 2012-2017.
Factor (n=1534)
Age (years)
65-69
70-74
75-79
80 and above
Gender
Female
Male
Race
White
African American
Other
Marital Status
Married
Single
Other
Hospitalization Within 30
days after an Antibiotic
Prescription
No
Yes
ER visit Within 30 days of
after Antibiotic prescription
No
Yes
Clinic
Geriatrics
Internal Medicine

Adjusted Odds Ratio
[95% CI])

Unadjusted Odds Ratio
[95% CI])

1 [Reference]
0.83 [0.55-1.26]
0.61 [0.31-1.19]
0.37 [0.12-1.11]

1 [Reference]
0.81 [0.60-1.09]
0.58 [0.42-0.80] ¶
0.37 [0.27-0.50] ¶

1 [Reference]
1.28 [0.97-1.69]

1 [Reference]
1.28 [0.99-1.66]

1 [Reference]
1.21 [0.95-1.54]
0.68 [0.33-1.37]

1 [Reference]
1.20 [0.95-1.50]
0.77 [0.39-1.54]

1 [Reference]
1.28 [0.90-1.82]
1.00 [0.75-1.33]

1 [Reference]
1.32 [0.95-1.84]
0.81 [0.63-1.04]

1 [Reference]
0.51 [0.26-1.02]

1 [Reference]
0.50 [0.29-0.87] ¶

1 [Reference]
1.03 [0.57-1.85]

1 [Reference]
0.72 [0.45-1.14]

1 [Reference]
0.73 [0.56-0.94] ¶

1 [Reference]
0.90 [0.71-1.15]
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Figure
3.1. The trend of infectious diseases diagnosed among older adults (65 years and older) in
Figure
Figure 3.2.
Internal Medicine and Geriatrics clinic per 10,000 visits at VCU Health from 2012-2017
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Antibiotic Prescribing Trend Among Geriatrics Clinic per 10,000 visits
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3.2. The trend of antibiotic prescribing among older adults (65 years and older) in Internal Medicine
Figure
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3.3. The trend of antibiotic treatment for UTI among older adults (65 years and older) in Internal
Figure
Medicine and Geriatrics clinic per 10,000 visits at VCU Health from 2012-2017

65

Antibiotic Treatment Among URI patients in Geriatrics Clinic Per 100 URI
Diagnoses
90

Antibiotic Rate per 100 URI Diagnoses

80
70
60
50
40
30
20
10
0
2012

2013

2014

2015

2016

Quinolones

Macrolides

Tetracyclines

First generation Cephalosporins

Second generation Cephalosporins

Penicillins

2017

sulfonamides

Antibiotic Treatment Among URI patients in Internal Medicine Ambulatory
Clinic Per 100 URI Diagnoses
Axis Antibiotic Rate per 100 URI Diagnoses

80
70
60
50
40
30
20
10
0
2012

2013

2014

2015

2016

Quinolones

Macrolides

Tetracyclines

First generation Cephalosporins

Second generation Cephalosporins

Penicillins

2017

sulfonamides
Figure 3.4.
Figure
3.4. The trend of antibiotic treatment for URI among older adults (65 years and older) in Internal
Medicine and Geriatrics clinic per 10,000 visits at VCU Health from 2012-2017
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Antibiotic Rate per 100 Skin infection Diagnoses
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Figure 3.5. The trend of antibiotic treatment for skin infections among older adults (65 years and older) in
Internal Medicine and Geriatrics clinic per 10,000 visits at VCU Health from 2012-2017
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Discussion:
This study tested the trends of infectious diseases and antibiotic prescribing
among the older adult population visiting VCU Health over the past five years (20122017) in two ambulatory care clinics (Internal Medicine and Geriatrics clinic). To our
knowledge, this is the first study to evaluate and compare the antibiotic prescribing
practices between internal medicine physicians and geriatricians who specialize in the
care of older adult patients in an academic medical center.
Overall, the estimate of the rate of potentially inappropriate antibiotic
prescriptions was 30% in the Geriatrics clinic and 28% in the Internal Medicine clinic.
Our estimate is higher than previously reported (18% among older adults from National
Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory Medical
Care Survey (NHAMCS) data).15 Another study conducted among the Medicare
population by Olesen, et al.16 reported that the estimate of antibiotic potentially
inappropriate prescriptions was 40%, which is slightly higher than we observed.
Although we have used the same methodological approach to define antibiotic
appropriateness as in the previous studies, the differences we have noted could be
related to the nature of our data regarding linking and coding the diseases with each
antibiotic. Also, the differences could be related to regional or institutional practice
differences. Moreover, in our study uses two years more recent data than Olesen’s
study, which could explain also the differences in prescribing over time.
Moreover, we found that UTI, URI, and skin infections are the most common
infectious diseases among the older adult outpatient population and this is consistent
with previous reports. 15,11,17 ,18 Among all infectious diseases the trend over time
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remained the same or only slightly increased/decreased and was not statistically
significant except for skin infections. Hersh et al., reported that skin and soft infections
nearly doubled among adults 45 years or older from 1997 to 2005. 19 The patterns of
infectious diseases were the same among both clinics over the study period. This could
be due to consistency of following diagnostic guidelines within the institution between
the two clinics. We were unable to test the trend of C.diff infection due to the low
number of cases documented in our data (C.diff infections= 5 cases overall).
The most common antibiotic classes prescribed in both clinics were quinolones,
macrolides, and 1st generation cephalosporins, which is consistent with Olsen et al. and
other studies.16, 5, 20, 21 We observed that the use of macrolides dropped in 2013 and
following years in both clinics (Figure 3.2). This behavior could have resulted from a
safety concern due to the announcement issued in 2013 by the US Food and Drug
Administration (FDA) warning that azithromycin could cause serious cardiovascular side
effects and death.22 In addition, the US FDA warned prescribers to restrict the use of
quinolones as first line therapy to treat certain infections such as acute bacterial
sinusitis and uncomplicated UTI due to potentially permanent side effects affecting
muscles, joints, nerves, and central nervous system.23 Likely due to this safety concern,
we observed a significant reduction in quinolone prescriptions since 2016 (Figures 3.2 &
Figure 3.4). These findings support that despite efforts to reduce antibiotic prescribing
(nationally and within VCU Health) safety concerns with specific antibiotics are more
likely to reduce use than overall concerns about antibiotic resistance.
We found that geriatricians prescribed more potentially inappropriate antibiotics
than internal medicine providers. Many factors may contribute to this observation. One
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factor may be differences in family/caregiver/patient pressure on geriatricians to
prescribe an antibiotic compared to internal medicine providers.24 Another possible
factor is that some of the patients in the geriatrics clinic may live in an assisted living
facility where the facility care adds pressure to prescribe antibiotics.9 Patients’
characteristics, severity of the illness and frailty could be higher in the geriatrics clinic
which could affect the prescriber’s decision to be more willing to prescribe antibiotics
assuming that the older adult has a weaker immune system.25,26
This study has several limitations. First, we used medical record data at VCU
Health, an academic medical center, which limits the generalizability of our results.
Second, we have used a validated methodology to evaluate antibiotic appropriateness,
but that method assumes that the diagnoses are accurate. This is not always the case
in real world patient care, especially among the older adult population. For example,
confusion often arises in distinguishing UTI and asymptomatic bacteriuria.27 Third, only
a few cases of C.diff infection were documented in the VCU Health outpatient medical
records, limiting our ability to test for the trend and the predictors of this disease in the
logistic regression models. Finally, we have tested for ER visit and hospitalization within
30 days after antibiotic prescribing, and this assumes that the ER visit and
hospitalization are due to antibiotic use and not any other cause.
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Conclusion:
In conclusion, antibiotic inappropriateness is an important issue among older
adult patients in both Geriatrics and Internal Medicine clinic. Despite the efforts to
reduce antibiotic prescribing (nationally and within VCU Health) safety concerns with
specific antibiotics are more likely to reduce use than overall concerns about antibiotic
resistance. Future studies are needed to evaluate the antibiotic appropriateness in a
larger level to include more diverse patient population.
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CHAPTER FOUR

Study 3: Antibiotic Use Among Older Adults Visiting The Emergency Department
at VCU Health from 2012-2017

77

Background:
Antibiotic resistance is a serious problem in the United States and worldwide that
is associated with significant impact on mortality and morbidity among all age groups.1, 2,
3

According to the World Health Organization (WHO), inappropriate antibiotic use or

overuse and lack of infection control were associated with increased antibiotic
resistance.4 A recent nationally representative study reported that antibiotics were one
of the top ten drug classes highly associated with emergency department (ED) visits for
adverse events in the United States.5 Several studies have reported that inappropriate
antibiotic utilization is prevalent among acute respiratory tract infected (ARTI) patients
visiting the ED.6,7 Sixty-one percent of ARTI patients received antimicrobial therapy and
older adults had the highest overall rate of antibiotic use compared to other age groups
(676 per 1,000 visits).
The ED is an important component of the health care system that provides care
for vulnerable populations including older adults. In 2015, there were an estimated 21
million visits by older adult patients to the ED in the US, accounting for 15.6% of all ED
visits.8 Among all ED patient visits, infectious diseases were one of the top twenty
primary diagnoses. In 2012, there were an estimated 3,123,909 ED visits due to
infectious diseases among older adults.9 Moreover, the geriatric population is the most
common age group visiting the ED due to adverse drug reactions.10
Many Americans rely on the ED for health care due to difficulties accessing primary
care offices and several other barriers reported previously.11 Although there are national
and global initiatives to combat antibiotic resistance by improving antibiotic prescribing
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practices in all settings, there is little known about antibiotic use among geriatric
populations in the ED. Therefore, the specific aims for this study are to:
1. Assess the trend of antibiotic use and infectious diseases among older adult
patients aged 65 years or older visiting the ED at VCU Health from 2012-2017.
2. Assess the trend of antibiotic use and infectious diseases among middle aged
patients aged 54 to 64 years visiting the ED at VCU Health from 2012-2017.
3. Compare the antibiotic appropriateness between older adult patients and middleaged patients visiting the ED at VCU Health from 2012-2017.
4. Assess the relationship between antibiotic appropriateness and sociodemographic characteristics, age group and antibiotic negative outcomes
including ED visits within 30 days after the initiation of antibiotics and
hospitalization within 30 days after the initiation of antibiotics.
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Methods:
Data Source:
The ED electronic medical records at VCU Health from 2012-2017 were used in
this study. The complete data was available through Cerner (Kansas City, Missouri,
U.S.) by the beginning of 2012, so we abstracted the data starting from that date. The
year 2017 was the most recent complete data available at the time of data
retrieval. VCU Health is an urban academic medical center in central Virginia. The data
was retrieved from the electronic medical records and billing records by the
Bioinformatics core of the VCU Center for Clinical and Translational Research (CCTR).
Study Design and sample selection:
A cross-sectional retrospective cohort study design was used to conduct this
study using the electronic medical records at VCU Health from 2012-2017.
Inclusion and Exclusion Criteria:
Only older adult patients (65 years or older) and middle-aged patients (54-64
years of age) who received antibiotic prescriptions during their ED visit at VCU Health
from 2012-2017 were included in this study. Oral and intravenous antibiotic
prescriptions were included in the study. All patients who received an antibiotic
prescription within 2 days of hospital discharge were excluded from the study to avoid
including hospital-related infections. Patients who received an antibiotic prescription that
was not prescribed on the day of the ED visit were excluded from the study. Any
patients diagnosed with a viral infection were excluded as well. Finally, any patient with
missing information in the medication file or diagnosis file was excluded from the study.
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Study Measures:
Demographic Characteristics:
Age, race, gender and marital status were collected from VCU Health’s ED
electronic medical records. Age was treated as categorical variable and categorized into
2 groups: older adults (65 years or older) and middle-aged adults (54-64 years of age).
Age was censored as patients 80 years or older were grouped together and their actual
age was not included in the dataset to protect patient confidentiality. The race variable
was categorized as white, African American, and other. The ‘other’ category in the race
variable includes American Indian/Alaskan, Asian, Native Hawaiian, and other. The
gender variable was categorized as male or female. Marital status was categorized as
married, single, and other. The ‘other’ category included divorced, separated, and
widowed.
Outcomes Measures:
Antibiotic Use Patterns:
Antibiotic use determination included only the medications classified as ‘antiinfective’ in the prescription files. The medication file was abstracted from the ED
electronic medical records (Cerner, Kansas City, Missouri, U.S.) and included the
medication name, category name, and strength. The medication file contains all of the
antibiotic prescriptions that each patient received over the study period, so a patient
could have multiple antibiotic prescriptions over the study period related to multiple ED
visits. Our dataset comprises eleven antibiotic categories including macrolides
(azithromycin, erythromycin), quinolones (ciprofloxacin, levofloxacin), sulfonamides
(sulfamethoxazole-trimethoprim), urinary anti-infectives (nitrofurantoin), penicillins/beta-
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lactamase inhibitors ( amoxicillin-clavulanate), miscellaneous antibiotics (metronidazole,
rifaximin), tetracyclines (tetracycline, doxycycline), first generation cephalosporins
(cephalexin), second generation cephalosporins (cefuroxime), third generation
cephalosporins (cefdinir, cefpodoxime), Lincomycin derivatives (clindamycin)
and aminopenicillins (amoxicillin). The trend of antibiotic prescribing over time was
tested across all indications in each age group and also separately for the three most
common infectious diseases in the older adult population (urinary tract infection (UTI),
upper respiratory tract infection (URI) and skin and soft tissue infection).
Infectious Disease Diagnoses:
The infectious disease diagnoses in the VCU Health data were identified using
the International Classification of Diseases ICD-9-CM codes assigned to each patient
during the ED visit. VCU Health converted to ICD-10-CM coding by the end of 2015, so
in our analysis, we have used both ICD-9-CM and ICD-10-CM codes. We included the
most common infectious diseases among older and middle-aged patients visiting the
VCU Health ED, which include UTI, URI, skin and soft tissue infections, pneumonia,
Clostridioides difficile (C. diff) infection and otitis media. Table 4.1 details the ICD-9-CM
and ICD-10-CM codes used to identify each infectious disease.
Antibiotic Appropriateness:
To estimate oral antibiotic appropriateness we used a validated method developed
by Fleming-Dutra et al.12 This study used a comprehensive methodology with a team of
experts systematically reviewing the national guidelines for antibiotic use for common
infectious diseases among the older adult population. The criteria for antibiotic
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appropriateness categorized antibiotic use into three tiers based on the clinical
diagnosis as follows:
1. Tier 1: Antibiotics almost always indicated: includes UTI, C.diff. infection and
pneumonia.
2. Tier 2: Antibiotics may be indicated: includes acute sinusitis, suppurative otitis
media, and some type of skin and soft tissue infections.
3. Tier 3: Antibiotics not indicated: Acute and chronic bronchitis, influenza, some
types of skin and soft tissue infection, and URI.
All the ICD-9-CM and ICD-10-CM codes included in each category are listed in Table
4.2.
Statistical Analyses:
Demographic characteristics were summarized by descriptive analyses
(frequency/percentage). Chi-square tests were used to assess the relationship between
the outcomes variables and the categorical demographic variables. To adjust for the ED
visit variability between age groups, we calculated the antibiotic rate normalizing each
year by the total ED visits for each age group separately. Trend analysis was performed
using the Cochran–Armitage test. A logistic regression model was developed after
checking that the assumptions of the model were met, and odds ratios and ninety-five
percent confidence intervals were reported for all estimates. All variables with α equal to
0.1 or less were included in the model and all variables were considered statistically
significant at α level of 0.05 or less. Statistical analyses were conducted using the
Statistical Analysis Software Version 9.4 (SAS v.9.4 (SAS Institute Inc, Cary, NC)).
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Ethical Considerations:
The Virginia Commonwealth University Institutional Review Board (VCU IRB)
reviewed and approved this study as exempt (VCU IRB NO: HM20013606).
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Table 4.1. ICD-9-CM and ICD-10-CM codes for each infectious disease included in the
study.
Type of infection
Urinary tract infection
Upper respiratory tract
infection
Pneumonia
Skin and soft tissue
infection
Otitis media
Clostridioides difficile
infection

ICD-9-CM or ICD-10-CM
'599' 'N39.0'
'478.9' '465.9' 'J06.9' '490' '491.21' '466' 'J20.9' 'J40' '491.9'
'461.9' 'J01.90' '473.9' 'J32.9' 'J01.00' '477.9' 'J30.9'
'486' 'Z87.01' 'J18.9' 'J18.8' '516.3' 'B96.1'
'682.6' '682.9' '682.6' '528.3' 'L03.90' 'L03.116' 'L03.115'
'H60.12'
'380.1' '381.1' 'H66.93' 'H66.92' 'H66.91' 'H66.90' '382.9'
'381.4'
'A04.7' '8.45'
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Table 4.2. Antibiotic appropriateness criteria according to Fleming-Dutra, et al.12
Diagnosis
Corresponding ICD-9-CM or ICD-10-CM
Tier 1: Antibiotics almost always indicated:
Urinary tract Infection
'599' 'N39.0'
Bacterial pneumonia
'486' 'Z87.01' 'J18.9' 'J18.8' '516.3' 'B96.1'
Clostridioides difficile infection
'A04.7' '8.45'
Tier 2: Antibiotics may be indicated:
Acute sinusitis
Skin, cutaneous and mucosal
infections
Suppurative otitis media
Tier 3: Antibiotics not indicated:

'461.9' 'J01.90' '473.9' 'J32.9' 'J01.00'
'382.9' 'H66.90' 'L03.115' 'L03.116' 'L03.90'
'528.3' '682.6' '682.9' '682.6'
'H66.91' '380.1' '381.1' 'H66.93' 'H66.92'

Acute and chronic bronchitis,
bronchiolitis, allergic rhinitis
non-suppurative otitis media
viral upper respiratory infection (URI)

'490' '491.21' '466' 'J20.9' 'J40' '491.9' '477.9'
'J30.9'
'381.4'
'478.9' '465.9' 'J06.9'
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Results:
Demographic Characteristics:
The sample size of this study is 6,343 middle-aged or older adult patients who
received an antibiotic dispensed and prescribed in the ED at VCU Health from 2012 to
2017. The proportion of antibiotic prescriptions was evenly distributed across both
genders and age groups. A higher proportion of whites and African Americans received
antibiotic prescriptions compared to other races. Moreover, 14% of middle-aged
patients who were prescribed antibiotics in the ED visited the ED again within 30 days
following that prescription compared to 11% among older adult patients. Table 4.3
details the demographic characteristics of antibiotic users in the ED at VCU Health from
2012-2017 in both age groups.
Antibiotic Appropriateness:
Among all of the antibiotic prescriptions that older adults received in the ED, 90%
were considered potentially appropriate, compared to 81% among middle-aged
patients. Eighteen percent of the antibiotic prescriptions received by the middle age
group were considered potentially inappropriate, compared to 9% among the older adult
patient. Antibiotic appropriateness practices were statistically different between different
antibiotic appropriateness tiers (p < 0.0001) (Table 4.4).
Infectious disease trends among older adult patients compared to middle- aged
patients:
In our study, most of the antibiotic indications were limited to six infectious
diseases including UTI, URI, pneumonia, skin and soft tissue infection, C. diff infection,
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and otitis media. In both age groups, the trend of infectious diseases seemed to be
stable from 2012-2017 except for three diseases: UTI, URI, and pneumonia. The three
most common infectious diseases among the middle-aged group were UTI, URI, and
pneumonia. Among middle-aged patients, URI dropped from 180 diagnoses per 10,000
ED visits in 2012 to 76 diagnoses in 2017. The same trend was observed in the UTI
diagnoses which declined from 136 diagnoses per 10,000 ED visits in 2012 to 122
diagnoses in 2017. The opposite trend was seen with pneumonia, where the cases
increased from 83 cases per 10,000 ED visits in 2012 to 102 cases in 2017. Among
older adults, UTI, pneumonia, URI and skin and soft tissue infections were the most
common diagnoses seen in the ED visits over the study period. UTI rates were stable
over the study period, while URI rates dropped from 98 to 54 cases per 10,000 ED visits
among older adults from 2012 to 2017. C.diff infection rates were stable over the study
period in both age groups. Figure 4.1 shows the trends over time from 2012-2017 in
both age groups at the ED at VCU Health.
Antibiotic trends among older adult patients compared to middle-aged patients:
Interestingly, we observed similar trends in terms of antibiotic prescriptions by
category between middle-aged and older adult patients visiting the ED at VCU Health
from 2012-2017 (Figure 4.2). Quinolones, penicillins, first generation and third
generation cephalosporins were the most common antibiotic classes prescribed in both
age groups. The rate of quinolone prescriptions dropped slightly over time in middleaged and older adults (from 215 to 206 and 400 to 372 per 10,000 ED visits,
respectively). On the other hand, the rate of penicillins almost doubled in middle-aged
and older adults (from 179 to 334 and from 288 to 541 per 10,000 ED visits,
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respectively). Third generation cephalosporin prescriptions were stable most of the
study period and increased from 2016 to 2017 in both age groups. The same
observations were seen with the remaining antibiotic categories.
Predictors of Receiving Potentially Inappropriate Antibiotics Among Older Adult
Patients Compared to Middle-Aged Patients:
Table 4.5 presents the results of multiple logistic regression model analysis
predicting potentially appropriate versus potentially inappropriate antibiotic prescriptions
with demographic characteristics and outcomes of interest as predictors. Multiple
logistic regression modelling found that middle-aged patients were 70% significantly
more likely to be prescribed potentially inappropriate antibiotics compared to older adult
patients adjusting for other predictors (95% CI [1.38-2.06]. African Americans, single
adults, and non-insured patients were significantly more likely to be prescribed
potentially inappropriate antibiotics in the ED at VCU Health adjusting for other
covariates. Gender and hospitalization or ED visits within 30 days after an antibiotic
prescription were not associated with antibiotic potentially inappropriateness practices in
the ED at VCU Health.
Antibiotic Prescribing for UTI, URI, and Skin and soft tissue Infections:
Among patients diagnosed with UTI in both age groups, third generation
cephalosporins, quinolinones, penicillins, and first generation cephalosporins were the
most common antibiotic categories prescribed over the study period (Figure 4.3). The
rate of quinolone prescriptions to treat UTIs in the ED dropped in older and middle-aged
patients from 22 prescriptions per 100 UTI diagnosis to 14, and from 19 to 7
respectively from 2012-2017. In contrast, the rate of penicillin prescribing almost

89

doubled over the study period from 6 prescriptions per 100 UTI diagnosis in 2012 to 15
in 2017 among older adult patients. A similar trend was observed in the middle-aged
group, with penicillin prescribing increasing from 7 to 16 prescriptions per 100 UTI
diagnoses from 2012-2017.
Figure 4.4 shows the antibiotic prescribing rate over time for the treatment of
patients with URI in both age groups. Macrolides, quinolones, tetracyclines and
penicillins were the most common antibiotic categories prescribed to treat URI in both
age groups. Among older adults who were treated for URI, the rate of macrolide,
quinolone, and penicillin prescriptions more than doubled over the study period. In
contrast, the rate of prescribing of all antibiotic categories dropped from 2012-2017
among middle-aged patients except for penicillins.
In our study, the treatment options for skin and soft tissue infections were limited
to clindamycin, penicillins, 1st generation cephalosporins, and tetracyclines. The rate of
penicillin prescribing increased significantly among older adults and middle-aged
patients, from 32 prescriptions to 46 per 100 skin and soft tissue infection diagnoses,
and from 18 to 45 prescriptions per 100 skin and soft tissue infection diagnoses
respectively. Figure 4.5 presents the treatment of patients diagnosed with skin infected
by antibiotic category from 2012-2017.
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Table 4.3. Demographic characteristics of those who received antibiotics in the
emergency department at VCU Health by age group from 2012 to 2017.
Factors (n=6343)
Gender
Male
Female
Race
White
African American
Other
Marital Status
Married
Single
Other
Hospitalization within 30
days of an antibiotic
prescription
Yes
No
ED visit within 30 days of
an antibiotic prescription
Yes
No

Aged 54-64 years
(Freq/%)

Aged 65 years and
older (Freq/%)

1725 (54.83)
1605 (50.20)

1421 (45.17)
1592 (49.80)

P-Value
0.0002

<0.0001
1337 (47.34)
1821 (56.96)
169 (55.23)

1487 (52.66)
1376 (43.04)
137 (44.77)
<0.0001

969 (46.52)
1181 (65.68)
1163 (48.38)

1114 (53.48)
617 (34.32)
1241 (51.62)
0.4765

301 (9.04)
3029 (90.96)

288 (9.56)
2725 (90.44)
0.0012

472 (14.17)
2858 (85.83)

345 (11.45)
2668 (88.55)
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Table 4.4. Antibiotic prescribing appropriateness by age group at the emergency department,
VCU Health from 2012-2017.
Antibiotic appropriateness
(n=6343)
Antibiotics Almost always
indicated
Antibiotics maybe indicated
Antibiotics not indicated

54-64 years old
(Freq/%)
2700 (81.08)

65 and older
(Freq/%)
2722 (90.34)

26 (0.78)
604 (18.14)

17 (0.56)
274 (9.09)

P-Value
<.0001

Table 4.5. Multiple logistic regression model assessing predictors of antibiotic
appropriateness among older adults and middle-aged patients visiting the emergency
department at VCU Health from 2012-2017.
Factors (n=6343)
Age (years)
65 and older
54-64
Gender
Female
Male
Race
White
African American
Other
Marital Status
Married
Single
Other
Hospitalization within 30 days
of an antibiotic prescription
No
Yes
ED visit within 30 days of an
antibiotic prescription
No
Yes

Adjusted Odds Ratio [95%
CI])

Unadjusted Odds Ratio [95%
CI])

1 [Reference]
2.14 [1.82-2.50]¶

1 [Reference]
2.30 [1.97-2.68] ¶

1 [Reference]
0.98 [0.84-1.13]

1 [Reference]
0.95 [0.82-1.10]

1 [Reference]
1.46 [1.24-1.71] ¶
1.25 [0.87-1.81]

1 [Reference]
1.73 [1.49-2.02] ¶
1.23 [0.85-1.76]

1 [Reference]
1.58 [1.29-1.93] ¶
1.53 [1.26-1.86] ¶

1 [Reference]
2.06 [1.70-2.49] ¶
1.70 [1.41-2.04] ¶

1 [Reference]
0.65 [0.47-0.90]

1 [Reference]
0.71 [0.54-0.93]

1 [Reference]
1.30 [1.02-1.65]¶

1 [Reference]
1.21 [0.98-1.48]
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Figure
4.3. 4.1.
Figure

The trend of infectious disease diagnoses per 10,000 visits among older adults (65
years and older) and middle- aged adults (54-64 years) in the emergency department at VCU
Health from 2012-2017
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Antibiotic Prescription Rate per 10,000 visits

The Trend of Antibiotic Prescriptions Among Middle-Aged
Patients Visiting the ED per 10,000 visits
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Figure 4.2. The trend of antibiotic prescriptions per 10,000 visits among older adults (65 years and
older) and middle-aged adults (54-64 years) in the emergency department at VCU Health from 20122017
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Figure 4.3. The trend of antibiotic prescribing for UTI per 100 UTI diagnoses among older adult
patients (65 years and older) and middle-aged adults (54-64 years) in the emergency department at
VCU Health from 2012-2017
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Antibiotic Prescribing Among Older Adult Patients with URI Visiting the ED
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Figure
4.4. The trend of antibiotic prescribing for URI per 100 URI diagnoses among older adult patients
(65 years and older) and middle-aged adults (54-64 years) in the emergency department at VCU Health
from 2012-2017.
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Antibiotic Prescription Rate per 100 Skin Infection
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Antibiotic Prescribing Among Older adults with Skin Infection Visiting
the ED per 100 Skin Infection diagnoses
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Figure 4.5. The trend of antibiotic prescribing for skin infections per 100 skin infection diagnoses
among older adult patients (65 years and older) and middle-aged adults (54-64 years) in the
emergency department at VCU Health from 2012-2017
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Discussion:
Our study evaluated the trend of infectious disease diagnoses and antibiotic
prescribing practices among older and middle-aged patients visiting the ED at VCU
Health from 2012-2017. This study presents the most common infectious diseases
diagnosed in the ED, and the most common antibiotics prescribed in the same setting.
In addition, we have evaluated the antibiotic prescribing practices for the most common
infectious diseases among older adult patients including, UTI, URI, and skin and soft
tissue infections. To the best of our knowledge, the trend of infectious diseases and
antibiotic appropriateness presenting at the ED in academic medical centers is still
unclear among older adult populations. This is the first study to compare antibiotic
appropriateness between older adults and middle age patients at the ED.
Inappropriate antibiotic use has been documented as a risk factor for antibiotic
resistance.13,14,15 The overall estimate of potentially inappropriate antibiotic
prescriptions in our study was 27%, similar to previous reports of 24% in the ED16 and
18% based on data from the National Ambulatory Medical Care Survey (NAMCS)
which included an ED patients,12 but lower than the 40% reported by Olesen, et al.17 in
the Medicare population. The Olesen, et al. study was not limited to ED patients, but
included outpatients as well.17 Nine percent of older adults’ antibiotic prescriptions were
deemed potentially inappropriate, which was lower than the 18% observed in middleaged patients, but this percentage may still be an important contributor to unnecessary
hospital admissions, preventable adverse drug reactions or unnecessary health care
costs.
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Goto, et al.9 found in a recent study conducted using nationally representative
data that lower respiratory infection, UTI, and pneumonia were among the five most
common infectious diseases among older adults visiting the ED, similar to what we
observed among older adult patients. The same pattern was found by Stone et al
among ED patients.7 except that skin and soft tissue infections were the most common
indications for antibiotic prescribing in the ED among all age groups.
Our results suggested that ED providers prescribed broad-spectrum antibiotics
more than narrow-spectrum antibiotics and that could be due to the nature of the ED
diagnosis process. For instance, quinolones and penicillins were the most commonly
prescribed antibiotics in the ED. Although the Food and Drug Administration (FDA)
released in 2016 a warning regarding the use of quinolones as a first-line therapy due to
serious adverse events, we observed an increase in quinolone prescribing. 18 This
behavior could be due to the antimicrobial susceptibility patterns in our study suggested
empiric treatment with quinolones rather than other antibiotic classes. In addition, a
possible explanation of the increased use of all antibiotic categories since 2016 was due
to the fact of CMS requiring all hospitals to implement the sepsis core measures.19
This study has several limitations. First, while we examined six years of data and
our sample size was large, our study was limited to one large academic medical center
and we cannot generalize our findings to other academic medical centers in the US.
Second, although we have used a validated definition of antibiotic appropriateness, the
definition relies only on the indication of each antibiotic prescription and assumes that
the diagnosis is accurate. For instance, all of the UTI diagnoses were considered
accurate, while in real world scenarios they can sometimes be inaccurate due to the
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confusion between UTI, which should be treated with antibiotics, and asymptomatic
bacteriuria, which should not be treated with antibiotics. Third, we have evaluated ED
visits and hospitalization within 30 days following antibiotic prescribing as negative
outcomes related to antibiotic consumption while in reality there are other potential
causes for the ED visits and hospitalizations we observed. Finally, our findings derive
from secondary analysis of data from electronic health records, and our results could be
underestimated or overestimated due to possibly inaccurate ICD-9/10 coding in the
medical records.
Conclusion:
In conclusion, Geriatric patients received fewer potentially inappropriate antibiotic
prescriptions compared to middle-aged patients. This study provides trend analysis
regarding the most common antibiotics prescribed for both older adults and middle-aged
patients, and this analysis could help to improve antibiotic prescribing practices in the
future among all ages and especially older adults who are at high risk of medication
complexity. This analysis can serve as a baseline to understand the impact of
interventions to improve antimicrobial use in the ED in the future. It can also be
benchmarked against prescribing in the ED in other academic medical centers to inform
development of best practices for antimicrobial stewardship in the ED in safety net
hospitals.
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CHAPTER FIVE
DISCUSSION
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Summary of Findings:
This dissertation consists of three investigations of issues related to antibiotic use
and associated complications among older adult patients visiting different health care
settings from the emergency department (ED) to outpatient clinics. The first study
examined the trend of antibiotic use among community-dwelling older adults using a
nationally representative dataset, the Medical Expenditure Panel Survey (MEPS), from
2011-2015. In this study, we evaluated the trend of common infectious diseases and the
association between antibiotic use and demographic characteristics, sociodemographic
characteristics, and the negative outcomes of antibiotic use such as ED visits. The
second study calculated the trend of antibiotic use and common infectious diseases
among older adult patients visiting VCU Health in two different outpatient clinics,
Geriatrics clinic and adult Internal Medicine clinic, from 2012-2017. We evaluated and
compared the antibiotic prescribing appropriateness practices between the two clinics.
The third study described the trend of antibiotic prescriptions among older adult patients
and compared it with middle-aged patients visiting the ED at VCU Health from 20122017. This study evaluated antibiotic use predictors and the prescribing appropriateness
practices between older adult patients and middle-aged patients. This chapter presents
the highlights of the main findings, implications of the studies’ results, and possible
future research.
Thirty-one percent of community-dwelling U.S. older adults reported using
antibiotics, accounting for 105,762,134 prescriptions from 2011-2015. In addition, the
overall rate of antibiotic prescriptions increased slightly over the study period from 484
prescriptions per 1,000 persons in 2011 to 540 prescriptions per 1,000 persons in 2015.
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This rate is higher than the rate of antibiotic use among a younger adult population in
2010 where a study reported that the rate was 354 prescriptions per 1,000 persons. 1
Several previous studies have reported mixed results regarding the antibiotic rate
among younger adults compared to an older adult population. These differences in the
overall antibiotic rate are possibly due to the nature of the dataset, and the
methodological approach for assessing antibiotic prescriptions. For those reasons it is
difficult to directly compare the antibiotic trends between populations using different
datasets. To the best of our knowledge, this study uses the most recently available data
to evaluate antibiotic use among older adult patients using nationally representative
data. Our analysis found that the rate of antibiotic prescribing varied by age group.
Younger older adults (65-69) received more antibiotic prescriptions compared to the
oldest-old group (80 years of age or older). Interestingly, antibiotic users were more
likely to visit the ED compared to non-users. Our analysis estimated that upper
respiratory tract infections were the most common antibiotic indications from 2011-2015,
and most of these indications do not require antibacterial therapy. Among antibiotic
users, macrolides, quinolones, and penicillins were the most common antibiotic
categories prescribed in the U.S. The rate of macrolide prescribing significantly
decreased while penicillins prescribing rates increased over the study period. These
findings support the hypothesis that health care professionals may not be reducing their
prescribing of antibiotics in response to calls to reduce use to avoid antibiotic
resistance, but rather they are changing prescribing from one antibiotic category to
another perhaps in response to drug safety concerns.
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Among VCU Health patients visiting adult ambulatory care clinics, Internal Medicine
clinic providers prescribed more antibiotic prescriptions compared to the Geriatrics clinic
(69% vs. 31%) respectively. In addition, we found that Geriatrics clinic providers
prescribed more potentially inappropriate antibiotic prescriptions compared to Internal
Medicine clinic providers. We may expect that the geriatrics patients are more likely to
have compromised immune response and that the geriatricians are erring on the side of
caution. In addition, patients visiting the geriatrics clinics are considered complex
patients, which means they are sicker than the Internal Medicine patients and older as
well. The rate of common infectious diseases among VCU Health patients was similar to
the national findings where UTI, URI, and skin infections were observed to be the most
common antibiotic indications. In addition, we observed similar patterns of antibiotic
categories prescribed between Internal Medicine clinic and the Geriatrics clinic with
quinolone and macrolide use decreasing over time and penicillins increasing slightly
along with first-generation cephalosporins. We found that the patterns of antibiotic
categories prescribed varied by the indication and were consistent with national
guidelines.2,3,4
Among the VCU Health ED patients, we found that older adult patients were
significantly less likely to receive potentially inappropriate antibiotic prescriptions
compared to middle-aged patients. In both age groups, UTI, URI, and pneumonia were
the three most common indications for antibiotic prescriptions. Similar to the previous
studies’ findings, broad-spectrum antibiotic prescribing was common in the ED patients,
irrespective of the age of the patients. Penicillins and quinolones were the most
common antibiotics prescribed for ED patients from 2012-2017 at VCU Health.
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Moreover, we found differences in the antibiotic categories prescribed based on the
indications in both age groups. Our findings from the studies at VCU Health are limited
in their generalizability to other academic medicine centers or other care settings. The
choice of the antibiotic prescribed depends in part on the formulary system and this is
likely to vary from one hospital to another.
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Implications:
Most of the previous studies of antibiotic use in the U.S. were not focused on the
older adult population specifically, a population that could be affected negatively by
antibiotic overuse or misuse due to several factors such as polypharmacy,
comorbidities, and normal biological and physiological changes with age that could
affect antibiotic pharmacokinetics/pharmacodynamics. Our nationally representative
findings could be used to evaluate the impact of national antimicrobial stewardship
programs and the National Action Plan for Combating Antibiotic-Resistant Bacteria for
decreasing the antibiotic resistance in 2020 as the programs are implemented by
establishing a baseline for comparison. These findings could also be used to compare
antibiotic prescribing and infectious diseases trends to those observed in different
datasets such as Medicare claims data. The findings from the VCU Health System
could be used to improve health care provider treatment practices in the care of older
adults, including practices in the Geriatrics clinic. Comparing our results with the
hospital antibiogram would be useful for the hospital administration to evaluate the
antibiotic stewardship program in the hospital. In addition, our findings could help other
health care providers like nurse practitioners and pharmacists to evaluate their
knowledge, practices towards antibiotic use among vulnerable population like older
adults and identify opportunities to improve care for this population and reduce the risk
of outcomes such as antibiotic resistance.
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Future Research:
In our retrospective cohort studies, we have assessed the antibiotic prescribing trends
on a national level and local level. In addition, we have evaluated antibiotic
appropriateness based on the ICD-codes, assuming the diagnosis is correct. Future
studies could test antibiotic prescription appropriateness through a more robust
definition taking into consideration the antibiotic susceptibility of each patient, accurate
diagnosis and lab culture, age-appropriate dosing and choice of antibiotic, and risk of
drug interactions. Moreover, antibiotic inappropriateness could be defined in different
ways, such as a patient receiving an antibiotic from a friend or family member or an
individual not following the correct directions for use. Taking all these factors into
consideration when defining antibiotic appropriateness measures will strengthen the
definition and the study’s findings.
In the three studies that we have conducted, we examined antibiotic use among
non-institutionalized older adults. Previous studies have shown that antibiotic
prescribing rates among older adult patients in the nursing home is high. The same
study objectives need to be replicated among nursing home residents using the most
recent nationally representative data. On the other hand, assisted living residents share
common characteristics with both community-dwelling older adults and nursing home
residents such as age, polypharmacy, and comorbidities that could affect the
medication prescription practices. There is a lack of research evaluating prescribing
practices in assisted living facilities. Unlike inpatient or nursing home settings, assisted
living facilities are a social model, not a medical model. For that reason, it is very difficult
to collect medical information regarding assisted living residents. Also, it is expensive
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and time and resource exhausting. A study that would compare and evaluate antibiotic
prescription practices among outpatient community older adults, nursing home
residents, and assisted living facilities residents would be ideal research questions for
future researchers.
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Appendix For Study 2

Appendix: 3.1 Infectious Diseases Trend in Internal Medicine Ambulatory Clinic per 10,000 visits
Type of Infection
UTI
URI
Pneumonia
Skin Infection
C.Diff
Otitis Media

2012
32.54149
31.45677
5.96594
10.30481
0
3.254149

2013
38.58728
25.72485
4.287475
11.79056
0
2.143738

2014
30.64295
29.00137
1.641587
7.660739
0
2.735978

2015
31.05939
17.58785
2.619466
2.993676
0
1.122628

2016
27.66742
31.21453
2.837684
4.611237
0
2.482974

2017
23.72053
28.39275
3.234618
5.750431
0.359402
1.79701

P-value
0.4745
0.1286
0.305
0.0021
0.0514
0.809

2016
78.18317
63.29114
3.723008
33.50707
0
0

2017
55.58363
60.63669
10.10611
75.79586
0
0

p-value
0.9833
0.2798
0.4479
0.3321
0.705
0.5651

Appendix 3.2 Infectious Diseases Trend in Geriatrics Clinic per 10,000 visits
Type of Infection
UTI
URI
Pneumonia
Skin Infection
C.Diff
Otitis Media

2012
60.84071
99.55752
5.530973
44.24779
0
0

2013
73.52941
71.07843
4.901961
39.21569
0
0

2014
71.71483
78.04261
14.76482
14.76482
0
6.327779

2015
77.50397
107.3132
21.8601
31.7965
1.987281
0
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Appendix 3.3 Antibiotic Prescriptions Trend among Geriatrics Clinic per 10,000 visits

Quinolones
Macrolides
Tetracyclines
First generation
Cephalosporins
Second generation
Cephalosporins
Third generation
Cephalosporins
Aminopenicillins
urinary anti-infectives
Miscellaneous Antibiotics
Penicillins
Sulfinamides

2012
176.9912
99.55752
49.77876
49.77876

2013
137.2549
88.23529
68.62745
58.82353

2014
166.6315
80.15187
37.96667
59.05927

2015
176.868
99.36407
65.58029
61.60572

2016
152.6433
78.18317
44.6761
81.90618

2017
106.1142
80.84891
75.79586
126.3264

0

7.352941 2.10926

0

2.45098

8.437039 17.88553 40.95309 45.47751

38.71681
11.06195
27.65487
22.12389
27.65487

34.31373
12.2549
24.5098
31.86275
34.31373

37.96667
10.5463
27.42038
50.62223
16.87408

1.987281 7.446016 10.10611

41.73291
19.87281
23.84738
53.6566
17.88553

29.78407
26.06106
22.33805
44.6761
7.446016

70.7428
35.3714
25.26529
65.68974
5.053057

Appendix 3.4 Antibiotic Prescriptions trend among Internal Medicine Ambulatory Care Clinic per 10,000 visits
Antibiotic Category
Quinolones
Macrolides
Tetracyclines
First generation
Cephalosporins
Second generation
Cephalosporins
Third generation
Cephalosporins
Aminopenicillins
urinary anti-infectives
Miscellaneous Antibiotics
Penicillins
sulfonamides

2012
63.45591
55.32053
21.15197
15.18603

2013
52.52157
42.87475
24.65298
13.39836

2014
46.51163
45.41724
21.88782
16.96306

2015
37.42095
30.31097
14.96838
11.60049

2016
40.08229
40.437
20.57321
21.28263

2017
30.54917
32.70558
20.12651
20.48591

p-value
0.0035
0.333
0.26
<.0001

0

1.071869

1.094391

0.748419

1.418842

1.79701

0.0403

2.711791

2.679672

2.188782

3.742095

5.320658

10.78206

<.0001

27.66027
8.135373
13.55895
11.38952
11.38952

17.68584
2.679672
9.110885
10.18275
6.431213

12.0383
9.302326
7.113543
10.39672
8.207934

7.48419
10.47787
6.361561
10.85207
5.238933

9.931896
6.030079
8.158343
14.18842
3.547106

10.06325
5.391029
6.109833
15.09488
5.031627

0.0002
0.4684
0.2539
0.0013
0.061
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Appendix 3.4 Antibiotic Treatment Among UTI patients in Geriatrics Clinic Per 100 UTI Diagnoses
Antibiotic Category
Quinolones
Macrolides
Tetracyclines

2012
81.81818
0
0

2013
36.66667
6.666667
3.333333

2014
61.76471
0
2.941176

First generation
Cephalosporins
Second generation
Cephalosporins
Third generation
Cephalosporins
urinary anti-infectives
Miscellaneous Antibiotics
Penicillins
sulfonamides

9.090909 23.33333 23.52941 10.25641 9.52381
0

2015
56.41026
0
2.564103

2017
18.18182
0
9.090909

P-value
0.096
0.5408
0.6706

9.090909 0.1424

0

0

0

3.333333 0

15.38462 28.57143 27.27273 0.0003

0
0
0
0

10
3.333333
10
23.33333

10.25641
5.128205
15.38462
0

0
8.823529
20.58824
5.882353

0

2016
52.38095
4.761905
0

4.761905 9.090909 0.0309

14.28571
4.761905
4.761905
0

9.090909
0
18.18182
0

0.2595
0.9621
0.7034
0.0041

Appendix 3.5 Antibiotic Treatment Among UTI Patients in Internal Medicine Ambulatory Care Clinic
Per 100 UTI Diagnoses
Antibiotic Category
Quinolones
Macrolides
Tetracyclines
First generation
Cephalosporins
Second generation
Cephalosporins
Third generation
Cephalosporins
urinary anti-infectives
Miscellaneous Antibiotics
Penicillins
sulfonamides

2012
66.66667
0
0
15

2013
62.5
4.166667
2.777778
8.333333

2014
50
5.357143
0
16.07143

2015
43.37349
1.204819
1.204819
20.48193

2016
51.28205
2.564103
3.846154
32.05128

2017
36.36364
3.030303
3.030303
33.33333

P-value
<.0001
0.8719
0.2159
0.0003

0

1.388889 1.785714 2.409639 3.846154 1.515152 0.3053

1.666667 6.944444 5.357143 8.433735 6.410256 15.15152 0.0273
3.333333
3.333333
6.666667
13.33333

1.388889
2.777778
11.11111
6.944444

12.5
0
8.928571
8.928571

18.07229
0
6.024096
8.433735

10.25641
0
3.846154
0

10.60606
1.515152
4.545455
3.030303

0.0376
0.0951
0.1019
0.0027
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Appendix 3.6 Antibiotic Treatment Among URI patients in Geriatrics Clinic Per 100 URI Diagnoses
Antibiotic Category
Quinolones
Macrolides
Tetracyclines
First generation
Cephalosporins
Second generation
Cephalosporins
Penicillins
sulfonamides

2012
22.22222
66.66667
5.555556
0

2013
17.24138
65.51724
0
0

2014
8.108108
54.05405
5.405405
0

2015
25.92593
50
1.851852
1.851852

2016
17.64706
52.94118
0
5.882353

2017
0
83.33333
0
0

P-value
0.562
0.6156
0.3586
0.2485

0

6.896552

0

0

0

0

0.1566

16.66667
0

13.7931
0

32.43243
2.702703

22.22222
1.851852

29.41176
0

16.66667
0

0.6303
0.9

Appendix 3.7 Antibiotic Treatment Among URI patients in Internal Medicine Ambulatory Care Clinic Per
100 URI Diagnoses
Antibiotic Category
Quinolones
Macrolides
Tetracyclines
First generation
Cephalosporins
Second generation
Cephalosporins
Penicillins
sulfonamides

2012
12.06897
68.96552
0
0

2013
10.41667
68.75
4.166667
0

2014
13.20755
64.15094
13.20755
3.773585

2015
19.14894
44.68085
6.382979
0

2016
6.818182
53.40909
18.18182
1.136364

2017
5.063291
41.77215
27.8481
1.265823

P-value
0.2113
0.0083
<.0001
0.5386

0

0

0

0

0

2.531646 0.0661

18.96552
1.724138

16.66667
0

11.32075
1.886792

23.40426
2.12766

19.31818
0

22.78481 0.1674
0
0.3051
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Appendix 3.8 Antibiotic Treatment Among Skin & Soft Tissue patients in Geriatrics Clinic Per 100 Skin & Soft
Tissue Diagnoses
Antibiotic Category
Quinolones
Macrolides
Tetracyclines
First generation
Cephalosporins
Third generation
Cephalosporins
Miscellaneous Antibiotics
Penicillins

2012
0
0
62.5
50

2013
12.5
0
62.5
18.75

2014
28.57143
0
28.57143
0

2015
0
0
31.25
18.75

2016
0
11.11111
11.11111
22.22222

2017
0
0
26.66667
66.66667

p-value
0.1818
0.4082
0.0161
0.0618

0

0

0

6.25

0

0

0.8148

0
0

0
12.5

28.57143 0
28.57143 50

0
0
33.33333 20

0.6098
0.1114

Appendix 3.9 Antibiotic Treatment Among Skin & Soft Tissue patients in Internal Medicine Ambulatory Care
Clinic Per 100 Skin & Soft Tissue Diagnoses
Antibiotic Category
Quinolones
Macrolides
Tetracyclines
First generation
Cephalosporins
Penicillins
Sulfonamides

2012
10.52632
0
57.89474
21.05263

2013
4.545455
0
59.09091
36.36364

2014
0
0
71.42857
50

2015
0
0
62.5
12.5

26.31579 22.72727 7.142857 12.5
0
4.545455 7.142857 12.5

2016
0
15.38462
38.46154
30.76923

2017
0
0
50
37.5

p-value
0.0738
0.126
0.8098
0.3642

7.692308 6.25
0
12.5

0.0158
0.1585
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Appendix For Study 3

Appendix 4.10 The Trend of Infectious Disease Diagnoses Among Middle-Aged Adults visiting the ED per 10,000 visits

Type of Infection
UTI
URI
Pneumonia
Skin Infection
C.Diff
Otitis Media

2012
136.5188
180.173
83.33995
76.99024
0
0

2013
143.8404
165.4938
103.6269
85.06689
0
18.56005

2014
145.7249
150.9294
98.14126
87.73234
0
11.15242

2015
113.9997
123.7314
89.67051
62.56082
0.69512
10.4268

2016
106.3759
75.79283
89.08982
53.18795
7.978193
6.648494

2017
122.5476
76.00306
102.5158
47.13368
8.248395
7.070052

P-value
0.0102
<.0001
<.0001
0.1377
<.0001
0.0433

Appendix 4.11 The Trend of Infectious Disease Diagnoses Among Older Adults visiting the ED per 10,000 visits

Type of Infection
UTI
URI
Pneumonia
Skin Infection
C.Diff
Otitis Media

2012
256.523
98.21167
121.6652
71.82644
0
10.26092

2013
265.8371
107.4661
173.9253
50.90498
0
7.070136

2014
258.0223
104.7806
145.3831
62.86837
0
3.929273

2015
230.1578
90.16491
151.8567
65.25092
1.18638
4.745521

2016
206.8732
44.08772
132.2632
37.305
21.47863
4.521818

2017
244.2297
54.57148
152.9791
65.30685
13.41922
4.473072
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P-value
0.8107
<.0001
0.0381
0.8792
<.0001
0.2189

Appendix 4.12 The Trend of Antibiotic Prescriptions Among Older Adult patients Visiting the ED per 10,000 visits
Quinolones
Macrolides
Tetracyclines
First generation Cephalosporins
Second generation Cephalosporins
Third generation Cephalosporins
Aminopenicillins
urinary anti-infectives
Miscellaneous Antibiotics
Penicillins
sulfonamides
Clindamycin

2012
400.1759
76.22398
48.37291
162.7089
14.65846
256.523
17.59015
7.329229
55.70214
288.7716
30.78276
38.11199

2013
395.9276
93.32579
52.319
197.9638
14.14027
263.009
14.14027
15.5543
97.56787
349.2647
32.52262
29.69457

2014
411.2639
87.75377
43.222
179.4368
9.168304
226.5881
17.02685
17.02685
81.20498
352.3248
41.91225
22.26588

2015
367.7779
74.74196
68.81006
213.5485
33.21865
224.2259
33.21865
16.60932
98.46957
387.9464
36.77779
30.84589

2016
334.6145
101.7409
62.17499
229.4823
22.60909
256.6132
23.73954
22.60909
98.34954
388.8763
33.91363
32.78318

2017 P-value
372.1596 <.0001
171.766
0.0043
67.9907
0.8911
279.1197
0.2708
19.68152
0.7515
396.3142
0.7441
26.83843
0.5824
43.83611
0.0003
124.3514
0.2425
541.2417
0.0142
54.57148
0.7505
29.52228
0.0338

Appendix 4.13 The Trend of Antibiotic Prescriptions Among Middle-Aged patients Visiting the ED per 10,000
visit

Antibiotic Category
Quinolones
Macrolides
Tetracyclines
First generation Cephalosporins
Second generation Cephalosporins
Third generation Cephalosporins
Aminopenicillins
urinary anti-infectives
Miscellaneous Antibiotics
Penicillins
sulfonamides
Clindamycin

2012
215.0964
82.54623
91.27709
181.7605
13.49313
109.5325
12.69942
9.524565
70.64053
179.3793
40.4794
26.19255

2013
232.774
92.02691
81.20022
155.4404
10.05336
111.3603
21.65339
13.92004
65.73351
220.4006
47.17346
29.38675

2014
211.1524
104.8327
66.9145
150.1859
14.86989
129.368
25.27881
10.40892
81.04089
240.1487
38.66171
25.27881

2015
229.3897
105.6583
66.03642
173.0849
27.10969
132.768
22.93897
9.731684
78.54859
235.6458
45.18282
22.93897

2016
211.4221
95.73832
48.53401
182.8336
20.61033
125.6565
25.26428
9.972741
81.77648
278.5719
43.88006
23.93458

2017
206.2099
138.4552
75.41389
214.4583
15.90762
177.3405
22.3885
18.85347
121.9584
334.06
54.79291
28.86938
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P-value
<.0001
0.1265
<.0001
0.6478
0.53
0.0482
0.7358
0.5361
0.0107
<.0001
0.7932
0.1383

Appendix 4.14 Antibiotic Treatment Among UTI Older Adult Patients Visiting the ED per 100 UTI Diagnoses

Antibiotic Category
Quinolones
Macrolides
Tetracyclines
First generation Cephalosporins
Second generation
Cephalosporins
Third generation
Cephalosporins
urinary anti-infectives
Miscellaneous Antibiotics
Penicillins
sulfonamides

2012
22.28571
0
0.571429
9.142857
0.571429

2013
15.42553
1.595745
0
8.510638
1.06383

2014
22.33503
0.507614
0
8.629442
0

2015
21.82741
0
0.507614
8.629442
0

2016
11.47541
3.278689
0.546448
11.47541
0

2017
14.28571
2.197802
0
17.58242
0

P-value
<.0001
0.0505
0.5952
0.0357
0.0263

32.57143 34.57447 28.93401 29.94924 38.79781 41.39194 0.9783
0.571429
0.571429
6.285714
1.142857

0.531915
3.723404
16.48936
1.06383

3.553299
4.060914
17.25888
3.553299

3.553299
7.106599
15.73604
3.553299

6.010929
1.639344
13.6612
5.464481

4.761905
1.465201
15.01832
4.029304

0.0039
0.3944
0.8968
0.0502

Appendix 4.15 Antibiotic Treatment Among UTI Middle-Aged Patients Visiting the ED per 100 UTI Diagnoses

Antibiotic Category
Quinolones
Macrolides
Tetracyclines
First generation Cephalosporins
Third generation
Cephalosporins
urinary anti-infectives
Miscellaneous Antibiotics
Penicillins
sulfonamides

2012
19.18605
0
0.581395
19.18605
14.53488

2013
27.41935
1.075269
0
15.5914
31.72043

2014
12.7551
2.55102
0.510204
17.34694
22.95918

2015
19.5122
1.829268
0
21.95122
23.17073

2016
11.25
0
0.625
15.625
20

2017
7.692308
1.923077
0.961538
22.59615
19.71154

P-value
<.0001
0.3902
0.384
0.3194
0.5293

1.744186
2.906977
7.55814
2.906977

4.83871
2.688172
8.064516
6.451613

5.612245
6.632653
16.83673
2.55102

1.219512
3.04878
10.36585
4.268293

3.75
1.875
10
0.625

8.173077
5.288462
16.82692
4.807692

0.036
0.5626
0.0161
0.6533

120

Appendix 4.16 Antibiotic Treatment Among URI Older Adult Patients Visiting the ED per 100 URI Diagnoses

Antibiotic Category
Quinolones
Macrolides
Tetracyclines
First generation Cephalosporins
Third generation
Cephalosporins
Penicillins

2012
8.955224
7.462687
8.955224
8.955224
2.985075

2013
31.57895
40.78947
6.578947
1.315789
14.47368

2014
13.75
23.75
11.25
0
8.75

7.462687 5.263158 8.75

2015
21.05263
21.05263
13.15789
1.315789
3.947368

2016
17.94872
33.33333
5.128205
0
7.692308

2017
5
26.66667
6.666667
1.666667
6.666667

P-value
0.0526
0.3746
0.6133
0.0084
0.5236

6.578947 12.82051 23.33333 0.0027

Appendix 4.17 Antibiotic Treatment Among URI Middle-Aged Patients Visiting the ED per 100 URI Diagnoses

Antibiotic Category
Quinolones
Macrolides
Tetracyclines
First generation Cephalosporins
Third generation
Cephalosporins
Penicillins

2012
14.43299
65.97938
48.45361
2.061856
3.092784

2013
27.27273
44.54545
31.81818
2.727273
1.818182

5.154639 20

2014
18.64407
39.83051
21.18644
0.847458
0.847458

2015
22.22222
68.88889
40
4.444444
0

2016
10
41.25
6.25
1.25
0

9.322034 17.77778 17.5

2017
13.75
50
20
3.75
2.5

P-value
0.8052
0.1673
0.0015
0.3195
0.4961

10

0.06
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Appendix 4.18 Antibiotic Treatment Among Skin & Soft Tissue Older Adult Patients Visiting the ED per 100 Skin
& Soft Tissue Diagnoses

Antibiotic Category
Quinolones
Tetracyclines
First generation Cephalosporins
Third generation Cephalosporins
Penicillins
Sulfonamides
Clindamycin

2012
6.122449
6.122449
8.163265
4.081633
32.65306
0
10.20408

2013
5.555556
5.555556
25
0
33.33333
5.555556
25

2014
4.166667
4.166667
8.333333
2.083333
37.5
4.166667
10.41667

2015
1.818182
10.90909
14.54545
3.636364
34.54545
5.454545
18.18182

2016
0
6.060606
12.12121
3.030303
54.54545
6.060606
21.21212

2017 p-value
1.369863
0.0171
2.739726
0.273
31.50685
0.0676
0
0.1924
46.57534
0.6719
5.479452
0.4076
16.43836
0.912

Appendix 4.19 Antibiotic Treatment Among Skin & Soft Tissue Middle-Aged Patients Visiting the ED per 100 Skin
& Soft Tissue Diagnoses

Antibiotic Category
Quinolones
Tetracyclines
First generation Cephalosporins
Third generation Cephalosporins
Penicillins
Sulfonamides
Clindamycin

2012
6.185567
7.216495
18.5567
4.123711
18.5567
9.278351
28.57143

2013
1.818182
10
20
0.909091
28.18182
9.090909
27.77778

2014
1.694915
8.474576
11.86441
0.847458
23.72881
11.01695
43.75

2015
3.333333
6.666667
18.88889
0
43.33333
4.444444
32.72727

2016
3.75
6.25
16.25
0
18.75
3.75
48.48485

2017 p-value
5
0.9462
7.5
0.4686
15
0.3092
5
0.8884
45
0.006
5
0.0379
19.17808
0.1167
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Appendix 5.1. Detailed of antibiotic categories that we included in the analyses of study
two and study three.
Antibiotic Category
008 Carbapenems
009 Cephalosporin

011 Macrolide
012 Miscellaneous antibiotics
013 Penicillins

014 Quinolones
015 Sulfonamides

016 Tetracyclines
017 Urinary anti-infective
240 Lincomycin

Medication Name
Doripenem, Doripenem, Ertapenem,
Imipenem, Meropenem.
All first generation cephalosporins,
All second generation cephalosporins, All
third generation cephalosporins, All fourth
generation cephalosporins, All fifth
generation cephalosporins.
Azithromycin, Clarithromycin, Dirithromycin,
Erythromycin
Aztreonam, Bacitacin, Chloramphenicol,
Colistimethate, Fosfomycine, Metronidazole,
All penicillinase resistant penicillins,
Antipsudomonal penicellins,
Aminopenicillins, Beta-lactamse inhibitors,
Natural penicillins.
Ciprofloxacin, Levofloxacin, Ofloxacin,
Sulfadiazine, Sulfamethoxazole,
Sulfamethoxazole-Trimethoprim,
Sulfasalazine
Doxycycline, Tetracycline,
Fosfomycin, Nitrofurantoin, Trimethoprim
Clindamycin
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